Author: "Jouvet, Philippe" / Topic: pediatrics - Searchworks@Jio Institute Digital Library Search Results

Your search keyword '"Jouvet, Philippe"' showing total 24 results

Start Over Author "Jouvet, Philippe" Topic pediatrics

24 results on '"Jouvet, Philippe"'

1. How to manage ventilation in pediatric acute respiratory distress syndrome?

Author: Kneyber MC, Jouvet PA, and Rimensberger PC
Subjects: Adolescent, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Intensive Care Units, Pediatric, Critical Care methods, High-Frequency Ventilation methods, Pediatrics methods, Respiratory Distress Syndrome therapy
Published: 2014
Full Text: View/download PDF

2. It is too early to declare early or late rescue high-frequency oscillatory ventilation dead.

Author: Essouri S, Emeriaud G, and Jouvet P
Subjects: Female, Humans, Male, Pediatrics methods, Respiration, Artificial methods, Respiratory Distress Syndrome therapy, Respiratory Distress Syndrome, Newborn therapy
Published: 2014
Full Text: View/download PDF

3. Understanding the global epidemiology of pediatric critical illness: the power, pitfalls, and practicalities of point prevalence studies.

Author: Weiss SL, Fitzgerald JC, Faustino EV, Festa MS, Fink EL, Jouvet P, Bush JL, Kissoon N, Marshall J, Nadkarni VM, and Thomas NJ
Subjects: Child, Humans, Critical Care statistics & numerical data, Critical Illness epidemiology, Cross-Sectional Studies, Pediatrics statistics & numerical data
Abstract: Objective: The point prevalence methodology is a valuable epidemiological study design that can optimize patient enrollment, prospectively gather individual-level data, and measure practice variability across a large number of geographic regions and healthcare settings. The objective of this article is to review the design, implementation, and analysis of recent point prevalence studies investigating the global epidemiology of pediatric critical illness., Data Sources: Literature review and primary datasets., Study Selection: Multicenter, international point prevalence studies performed in PICUs since 2007., Data Extraction: Study topic, number of sites, number of study days, patients screened, prevalence of disease, use of specified therapies, and outcomes., Data Synthesis: Since 2007, five-point prevalence studies have been performed on acute lung injury, neurologic disease, thromboprophylaxis, fluid resuscitation, and sepsis in PICUs. These studies were performed in 59-120 sites in 7-28 countries. All studies accounted for seasonal variation in pediatric disease by collecting data over multiple study days. Studies screened up to 6,317 patients and reported data on prevalence and therapeutic variability. Three studies also reported short-term outcomes, a valuable but atypical data element in point prevalence studies. Using these five studies as examples, the advantages and disadvantages and approach to designing, implementing, and analyzing point prevalence studies are reviewed., Conclusions: Point prevalence studies in pediatric critical care can efficiently provide valuable insight on the global epidemiology of disease and practice patterns for critically ill children.
Published: 2014
Full Text: View/download PDF

4. Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*.

Author: Santschi M, Randolph AG, Rimensberger PC, and Jouvet P
Subjects: Blood Gas Analysis, Extracorporeal Membrane Oxygenation, Humans, Hypercapnia epidemiology, Hypoxia epidemiology, Prone Position, Pulmonary Surfactants administration & dosage, Tidal Volume, Acute Lung Injury therapy, Pediatrics, Respiration, Artificial methods
Abstract: Objectives: The aim of this survey was to determine North American and European pediatric intensivists' knowledge and stated practice in the management of children with acute respiratory distress syndrome with regard to mechanical ventilation settings; blood gas and SO2 targets; and use of adjunctive treatments at sites where actual practice had just been assessed., Design and Setting: A survey using three case scenarios to assess mechanical ventilation strategies used in children with acute respiratory distress syndrome was sent out toward the end of data collection to all centers participating in the Pediatric Acute Lung Injury Mechanical Ventilation study (59 PICUs in 12 countries). For each case scenario, intensivists were asked to report the optimal mechanical ventilation parameters; blood gas and SO2 acceptable targets; and threshold for considering high-frequency oscillatory ventilation, and other adjunctive treatments., Participants: Fifty-four pediatric intensivists, representing 47 centers from 11 countries., Interventions: None., Measurements and Main Results: Many pediatric intensivists reported using a tidal volume of 5-8 mL/kg (88-96%) and none reported using a tidal volume above 10 mL/kg. On average, the upper threshold of positive inspiratory pressure at which intensivists would consider another ventilation mode was 35 cm H2O. Permissive hypercapnia and mild hypoxemia (SO2 as low as 88%) was considered tolerable by many pediatric intensivists. Finally, a large proportion of pediatric intensivists reported they would use adjunctive treatments (nitric oxide, prone position, extracorporeal membrane oxygenation, surfactant, steroids, β-agonists) if the patient's condition worsened., Conclusions: Although in theory, many pediatric intensivists agreed with adult recommendations to ventilate with lower tidal volumes and pressure limits, the Pediatric Acute Lung Injury Mechanical Ventilation data revealed that over 25% of pediatric patients with acute lung injury/acute respiratory distress syndrome at many of these practice sites were ventilated with tidal volumes above 10 mL/kg and that high positive inspiratory pressure levels (> 35 mm Hg) were often tolerated.
Published: 2013
Full Text: View/download PDF

5. Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit

Author: Brossier, David, Goyer, Isabelle, Ziani, Lydia, Marquis, Christopher, Mitchell, Grant, Ozanne, Bruno, and Jouvet, Philippe
Published: 2018
Full Text: View/download PDF

6. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Author: Abdukahil, Sheryl, Hssain, Ali, Tamlihat, Younes, Alidjnou, Kazali, de Brito, Carlos, Assie, Jean, Rincon, Diego, Humaid, Felwa, Bosse, Hans, Calvache, Jose, Carrier, François, Cavalli, Giulio, Cheng, Matthew, Cho, Hwa, Cho, Sung, Cidade, Jose, Herreros, Jose, Citarella, Barbara, Colombo, Sebastiano, Corpuz, Arianne, D’orleans, Charles, de Oliveira França, Rafael, Dewayanti, Santi, Diaz, Juan, Douglas, James, Mangoni, Emanuele, Dyrhol-Riise, Anne, Vidal, José, Sanharawi, Mohammed, Everding, Anna, Fatoni, Arie, Devouge, Eglantine, Florio, Letizia, Fonseca, Claudio, Freire, Marcela, Ribeiro, Ana, Curto, Elena, Morlaes, Louis, Grandin, Edward, Grieco, Domenico, Lordemann, Anja, Ho, Antonia, Holter, Jan, Horcajada, Juan, Dominguez, Carmen, Sotomayor, Ruth, García, Ruth, Kandamby, Darshana, Johal, Simreen, Kildal, Anders, Bekken, Gry, Vasconcelos, Malte, Vecham, Pavan, Lantang, Eka, Santos, Marta, Lee, Su, Bassi, Gianluigi, Lim, Wei, Lucet, Jean, Müller, Karl, Sanchez, Juan, Maier, Lars, Sant, Ceila, Eid, Charbel, Martelli, Celina, Rego, Caroline, Marwali, Eva, Jimenez, Juan, Maldonado, Hugo, Tutillo, Diego, Perrot, Clara, Myrodia, Dimitra, Ng, Pauline, Ng, Wing, Choileain, Orna, Oinam, Budha, Oliveira, Ana, Orozco-Chamorro, Claudia, Panda, Prasan, Reyes, Luis, Rios, Ana, Nuñez, Maria, Abreu, Julia, Holten, Aleksander, Choez, Xavier, Shum, Hoi, Mohammed, Nassima, Silva, Maria, Sin, Wai, Song, Myung, Uva, Maria, Svistunov, Magdalena, Thuy, Duong, Vijayaraghavan, Bharath, Santos-Olmo, Rosario, Trieu, Huynh, Villanueva, Joy, Abdukahil, Sheryl Ann, Abe, Ryuzo, Abel, Laurent, Absil, Lara, Acker, Andrew, Adachi, Shingo, Adam, Elisabeth, Adrião, Diana, Ainscough, Kate, Hssain, Ali Ait, Tamlihat, Younes Ait, Akimoto, Takako, Al-Dabbous, Tala, Al-Fares, Abdulrahman, Al Qasim, Eman, Alalqam, Razi, Alex, Beatrice, Alexandre, Kévin, Alfoudri, Huda, Alidjnou, Kazali Enagnon, Aliudin, Jeffrey, Allavena, Clotilde, Allou, Nathalie, Alves, João, Alves, Rita, Amaral, Maria, Ammerlaan, Heidi, Ampaw, Phoebe, Andini, Roberto, Andrejak, Claire, Angheben, Andrea, Angoulvant, François, Ansart, Séverine, Antonelli, Massimo, de Brito, Carlos Alexandre Antunes, Arabi, Yaseen, Aragao, Irene, Arcadipane, Antonio, Arenz, Lukas, Arlet, Jean-Benoît, Arnold-Day, Christel, Arora, Lovkesh, Artaud-Macari, Elise, Asensio, Angel, Assie, Jean Baptiste, Atique, Anika, Auchabie, Johann, Aumaitre, Hugues, Azemar, Laurène, Azoulay, Cécile, Bach, Benjamin, Bachelet, Delphine, Baillie, J. Kenneth, Bak, Erica, Bakakos, Agamemnon, Banisadr, Firouzé, Barbalho, Renata, Barclay, Wendy, Barnikel, Michaela, Barrelet, Audrey, Barrigoto, Cleide, Basmaci, Romain, Rincon, Diego Fernando Bautista, Bedossa, Alexandra, Behilill, Sylvie, Beljantsev, Aleksandr, Bellemare, David, Beltrame, Anna, Beluze, Marine, Benech, Nicolas, Benkerrou, Dehbia, Bennett, Suzanne, Bento, Luís, Berdal, Jan-Erik, Bergeaud, Delphine, Bertolino, Lorenzo, Bessis, Simon, Bevilcaqua, Sybille, Bhavsar, Krishna, Humaid, Felwa Bin, Bissuel, François, Biston, Patrick, Bitker, Laurent, Blanco-Schweizer, Pablo, Blot, Mathieu, Boccia, Filomena, Bogaert, Debby, Bompart, François, Booth, Gareth, Borges, Diogo, Borie, Raphaël, Bos, Jeannet, Bosse, Hans Martin, Botelho-Nevers, Elisabeth, Bouadma, Lila, Bouchaud, Olivier, Bouchez, Sabelline, Bouhmani, Dounia, Bouhour, Damien, Bouiller, Kévin, Bouillet, Laurence, Bouisse, Camille, Boureau, Anne-Sophie, Bouscambert, Maude, Bouziotis, Jason, Boxma, Bianca, Boyer-Besseyre, Marielle, Boylan, Maria, Braga, Cynthia, Brandenburger, Timo, Brazzi, Luca, Breen, Dorothy, Breen, Patrick, Brickell, Kathy, Brozzi, Nicolas, Buchtele, Nina, Buesaquillo, Christian, Bugaeva, Polina, Buisson, Marielle, Burhan, Erlina, Bustos, Ingrid, Butnaru, Denis, Cárcel, Sheila, Cabie, André, Cabral, Susana, Caceres, Eder, Callahan, Mia, Calligy, Kate, Calvache, Jose Andres, Camões, João, Campana, Valentine, Campbell, Paul, Canepa, Cecilia, Cantero, Mireia, Caraux-Paz, Pauline, Cardoso, Filipa, Cardoso, Filipe, Cardoso, Sofia, Carelli, Simone, Carlier, Nicolas, Carney, Gayle, Carpenter, Chloe, Carret, Marie-Christine, Carrier, François Martin, Carson, Gail, Casanova, Maire-Laure, Cascão, Mariana, Casimiro, José, Cassandra, Bailey, Castañeda, Silvia, Castanheira, Nidyanara, Castor-Alexandre, Guylaine, Castrillón, Henry, Castro, Ivo, Catarino, Ana, Catherine, François-Xavier, Cavalin, Roberta, Cavalli, Giulio Giovanni, Cavayas, Alexandros, Ceccato, Adrian, Cervantes-Gonzalez, Minerva, Chair, Anissa, Chakveatze, Catherine, Chan, Adrienne, Chand, Meera, Chas, Julie, Chassin, Camille, Chen, Anjellica, Chen, Yih-Sharng, Cheng, Matthew Pellan, Cheret, Antoine, Chiarabini, Thibault, Chica, Julian, Chirouze, Catherine, Chiumello, Davide, Cho, Hwa Jin, Cho, Sung Min, Cholley, Bernard, Cidade, Jose Pedro, Herreros, Jose Miguel Cisneros, Citarella, Barbara Wanjiru, Ciullo, Anna, Clarke, Jennifer, Clohisey, Sara, Codan, Cassidy, Cody, Caitriona, Coelho, Alexandra, Colin, Gwenhaël, Collins, Michael, Colombo, Sebastiano Maria, Combs, Pamela, Connelly, J., Connor, Marie, Conrad, Anne, Contreras, Sofía, Cooke, Graham, Copland, Mary, Cordel, Hugues, Corley, Amanda, Cormican, Sarah, Cornelis, Sabine, Corpuz, Arianne Joy, Corvaisier, Grégory, Couffignal, Camille, Couffin-Cadiergues, Sandrine, Courtois, Roxane, D’orleans, Charles Crepy, Croonen, Sabine, Crowl, Gloria, Crump, Jonathan, Cruz, Claudina, Csete, Marc, Cucino, Alberto, Cullen, Caroline, Cummings, Matthew, Curley, Gerard, Curlier, Elodie, Custodio, Paula, D’aragon, Frédérick, da Silva Filipe, Ana, da Silveira, Charlene, D’ortenzio, Eric, Dabaliz, Al-Awwab, Dagens, Andrew, Dalton, Heidi, Dalton, Jo, Daneman, Nick, Dankwa, Emmanuelle, Dantas, Jorge, de Castro, Nathalie, de Mendoza, Diego, de Oliveira França, Rafael Freitas, de Rosa, Rosanna, de Silva, Thushan, de Vries, Peter, Dean, David, Debray, Marie-Pierre, Dechert, William, Deconninck, Lauren, Decours, Romain, Delacroix, Isabelle, Delavigne, Karen, Deligiannis, Ionna, Dell’amore, Andrea, Delobel, Pierre, Demonchy, Elisa, Denis, Emmanuelle, Deplanque, Dominique, Depuydt, Pieter, Desai, Mehul, Descamps, Diane, Desvallée, Mathilde, Dewayanti, Santi Rahayu, Diallo, Alpha, Diamantis, Sylvain, Dias, André, Diaz, Juan Jose Diaz, Diaz, Rodrigo, Didier, Kévin, Diehl, Jean-Luc, Dieperink, Wim, Dimet, Jérôme, Dinot, Vincent, Diouf, Alphonsine, Dishon, Yael, Djossou, Félix, Docherty, Annemarie, Dong, Andy, Donnelly, Christl, Donnelly, Maria, Donohue, Chloe, Dorival, Céline, Douglas, James Joshua, Douma, Renee, Dournon, Nathalie, Downer, Triona, Downing, Mark, Drake, Tom, Dubee, Vincent, Dubos, François, Ducancelle, Alexandra, Dudman, Susanne, Dunning, Jake, Mangoni, Emanuele Durante, Duranti, Silvia, Durham, Lucian, Dussol, Bertrand, Duval, Xavier, Dyrhol-Riise, Anne Margarita, Eira, Carla, Vidal, José Ernesto, Sanharawi, Mohammed El, Elapavaluru, Subbarao, Elharrar, Brigitte, Elkheir, Natalie, Ellerbroek, Jacobien, Ellis, Rachael, Eloy, Philippine, Elshazly, Tarek, Enderle, Isabelle, Engelmann, Ilka, Enouf, Vincent, Epaulard, Olivier, Esperatti, Mariano, Esperou, Hélène, Esposito-Farese, Marina, Estevão, João, Etienne, Manuel, Ettalhaoui, Nadia, Everding, Anna Greti, Evers, Mirjam, Fabre, Isabelle, Faheem, Amna, Fahy, Arabella, Fairfield, Cameron, Faria, Pedro, Farshait, Nataly, Fatoni, Arie Zainul, Faure, Karine, Fayed, Mohamed, Feely, Niamh, Fernandes, Jorge, Fernandes, Marília, Fernandes, Susana, Ferrão, Joana, Devouge, Eglantine Ferrand, Ferraz, Mário, Ferreira, Benigno, Ferrer-Roca, Ricard, Figueiredo-Mello, Claudia, Flateau, Clara, Fletcher, Tom, Florio, Letizia Lucia, Foley, Claire, Fomin, Victor, Fonseca, Claudio Duarte, Fonseca, Tatiana, Fontela, Patricia, Forsyth, Simon, Foti, Giuseppe, Fourn, Erwan, Fowler, Rob, Franch-Llasat, Diego, Fraser, Christophe, Fraser, John, Freire, Marcela Vieira, Ribeiro, Ana Freitas, Friedrich, Caren, Fry, Stéphane, Fuentes, Nora, Fukuda, Masahiro, Gómez-Junyent, Joan, Gaborieau, Valérie, Gachet, Benoît, Gaci, Rostane, Gagliardi, Massimo, Gagnard, Jean-Charles, Gagneux-Brunon, Amandine, Gaião, Sérgio, Gallagher, Phil, Curto, Elena Gallego, Gamble, Carrol, Garan, Arthur, Garcia-Gallo, Esteban, Garcia, Rebekha, Garot, Denis, Garrait, Valérie, Gault, Nathalie, Gavin, Aisling, Gaymard, Alexandre, Gebauer, Johannes, Morlaes, Louis Gerbaud, Germano, Nuno, Ghosn, Jade, Giani, Marco, Giaquinto, Carlo, Gibson, Jess, Gigante, Tristan, Gilg, Morgane, Giordano, Guillermo, Girvan, Michelle, Gissot, Valérie, Giwangkancana, Gezy, Glikman, Daniel, Glybochko, Petr, Gnall, Eric, Goco, Geraldine, Goehringer, François, Goepel, Siri, Goffard, Jean-Christophe, Golob, Jonathan, Gorenne, Isabelle, Goujard, Cécile, Goulenok, Tiphaine, Grable, Margarite, Grandin, Edward Wilson, Granier, Pascal, Grasselli, Giacomo, Green, Christopher, Greenhalf, William, Greffe, Segolène, Grieco, Domenico Luca, Griffee, Matthew, Griffiths, Fiona, Grigoras, Ioana, Groenendijk, Albert, Lordemann, Anja Grosse, Gruner, Heidi, Gu, Yusing, Guedj, Jérémie, Guellec, Dewi, Guerguerian, Anne-Marie, Guerreiro, Daniela, Guery, Romain, Guillaumot, Anne, Guilleminault, Laurent, Guimard, Thomas, Haber, Daniel, Hakak, Sheeba, Hall, Matthew, Halpin, Sophie, Hamer, Ansley, Hamidfar, Rebecca, Hammond, Terese, Hardwick, Hayley, Harley, Kristen, Harrison, Ewen, Harrison, Janet, Hays, Leanne, Heerman, Jan, Heggelund, Lars, Hendry, Ross, Hennessy, Martina, Henriquez-Trujillo, Aquiles, Hentzien, Maxime, Hernandez-Montfort, Jaime, Hidayah, Astarini, Higgins, Dawn, Higgins, Eibhilin, Hinton, Samuel, Hipólito-Reis, Ana, Hiraiwa, Hiroaki, Hiscox, Julian, Ho, Antonia Ying Wai, Hoctin, Alexandre, Hoffmann, Isabelle, Hoiting, Oscar, Holt, Rebecca, Holter, Jan Cato, Horby, Peter, Horcajada, Juan Pablo, Hoshino, Koji, Hoshino, Kota, Hough, Catherine, Hsu, Jimmy Ming-Yang, Hulot, Jean-Sébastien, Ijaz, Samreen, Illes, Hajnal-Gabriela, Inácio, Hugo, Dominguez, Carmen Infante, Iosifidis, Elias, Irvine, Lacey, Isgett, Sarah, Isidoro, Tiago, Isnard, Margaux, Itai, Junji, Ivulich, Daniel, Jaafoura, Salma, Jabot, Julien, Jackson, Clare, Jamieson, Nina, Jaureguiberry, Stéphane, Javidfar, Jeffrey, Jean-Benoît, Zabbe, Jego, Florence, Jenum, Synne, Sotomayor, Ruth Jimbo, García, Ruth Noemí Jorge, Joseph, Cédric, Joseph, Mark, Jouvet, Philippe, Jung, Hanna, Kafif, Ouifiya, Kaguelidou, Florentia, Kali, Sabina, Kalomoiri, Smaragdi, Kandamby, Darshana Hewa, Kandel, Chris, Kant, Ravi, Kartsonaki, Christiana, Kasugai, Daisuke, Katz, Kevin, Johal, Simreen Kaur, Keating, Sean, Kelly, Andrea, Kelly, Sadie, Kennedy, Lisa, Kennon, Kalynn, Kerroumi, Younes, Kestelyn, Evelyne, Khalid, Imrana, Khalil, Antoine, Khan, Coralie, Khan, Irfan, Kho, Michelle, Khoo, Saye, Kida, Yuri, Kiiza, Peter, Kildal, Anders Benjamin, Kimmoun, Antoine, Kindgen-Milles, Detlef, Kitamura, Nobuya, Klenerman, Paul, Bekken, Gry Kloumann, Knight, Stephen, Kobbe, Robin, Vasconcelos, Malte Kohns, Korten, Volkan, Kosgei, Caroline, Krawczyk, Karolina, Vecham, Pavan Kumar, Kumar, Deepali, Kurtzman, Ethan, Kutsogiannis, Demetrios, Kyriakoulis, Konstantinos, L’her, Erwan, Lachatre, Marie, Lacoste, Marie, Laffey, John, Lagrange, Marie, Laine, Fabrice, Lambert, Marc, Lamontagne, François, Langelot-Richard, Marie, Lantang, Eka Yudha, Lanza, Marina, Laouénan, Cédric, Laribi, Samira, Lariviere, Delphine, Launay, Odile, Lavie-Badie, Yoan, Law, Andrew, Le Bihan, Clément, Le Bris, Cyril, Le Coustumier, Eve, Le Falher, Georges, Le Gac, Sylvie, Le Hingrat, Quentin, Le Maréchal, Marion, Le Mestre, Soizic, Le Moing, Vincent, Le Nagard, Hervé, Le Turnier, Paul, León, Rafael, Le, Minh, Santos, Marta Leal, Leal, Ema, Lee, James, Lee, Su Hwan, Lee, Todd, Leeming, Gary, Lefebvre, Bénédicte, Lefebvre, Laurent, Lefevre, Benjamin, Lellouche, François, Lemaignen, Adrien, Lemee, Véronique, Lemmink, Gretchen, Leone, Michela, Lepiller, Quentin, Lescure, François-Xavier, Lesens, Olivier, Lesouhaitier, Mathieu, Levy-Marchal, Claire, Levy, Bruno, Levy, Yves, Bassi, Gianluigi Li, Liang, Janet, Lim, Wei Shen, Lina, Bruno, Lind, Andreas, Lingas, Guillaume, Lion-Daolio, Sylvie, Liu, Keibun, Loforte, Antonio, Lolong, Navy, Lopes, Diogo, Lopez-Colon, Dalia, Loubet, Paul, Lucet, Jean Christophe, Luna, Carlos, Lungu, Olguta, Luong, Liem, Luton, Dominique, Lyons, Ruth, Müller, Fredrik, Müller, Karl Erik, Maasikas, Olavi, Macdonald, Sarah, Machado, Moïse, Macheda, Gabrielle, Sanchez, Juan Macias, Madhok, Jai, Mahieu, Rafael, Mahy, Sophie, Maier, Lars Siegfrid, Maillet, Mylène, Maitre, Thomas, Malfertheiner, Maximilian, Malik, Nadia, Maltez, Fernando, Malvy, Denis, Mambert, Marina, Manda, Victoria, Mandei, Jose, Manning, Edmund, Manuel, Aldric, Sant, Ceila Maria, Malaque, Ana, Marino, Flávio, de Araújo Mariz, Carolline, Eid, Charbel Maroun, Marques, Ana, Marquis, Catherine, Marsh, Brian, Marsh, Laura, Marshall, John, Martelli, Celina Turchi, Martin-Blondel, Guillaume, Martin-Loeches, Ignacio, Martin-Quiros, Alejandro, Martin, Dori-Ann, Martin, Emily, Martinot, Martin, Rego, Caroline Martins, Martins, Ana, Martins, João, Martucci, Gennaro, Marwali, Eva Miranda, Jimenez, Juan Fernado Masa, Maslove, David, Mason, Sabina, Matan, Moshe, Mathieu, Daniel, Mattei, Mathieu, Matulevics, Romans, Maulin, Laurence, Mc Evoy, Natalie, Mccarthy, Aine, Mccloskey, Colin, Mcconnochie, Rachael, Mcdermott, Sherry, Mcdonald, Sarah, Mcelwee, Samuel, Mcevoy, Natalie, Mcgeer, Allison, Mcguinness, Niki, Mclean, Kenneth, Mcnicholas, Bairbre, Meaney, Edel, Mear-Passard, Cécile, Mechlin, Maggie, Mele, Ferruccio, Menon, Kusum, Mentré, France, Mentzer, Alexander, Mercier, Noémie, Merckx, Antoine, Mergler, Blake, Merson, Laura, Mesquita, António, Meybeck, Agnès, Meynert, Alison, Meyssonnier, Vanina, Meziane, Amina, Mezidi, Medhi, Michelanglei, Céline, Mihnovitš, Vladislav, Maldonado, Hugo Miranda, Mone, Mary, Moin, Asma, Molina, David, Molinos, Elena, Monteiro, Agostinho, Montes, Claudia, Montrucchio, Giorgia, Moore, Sarah, Moore, Shona, Morales-Cely, Lina, Moro, Lucia, Tutillo, Diego Rolando Morocho, Motos, Ana, Mouquet, Hugo, Perrot, Clara Mouton, Moyet, Julien, Mullaert, Jimmy, Munblit, Daniel, Murphy, Derek, Murris, Marlène, Myrodia, Dimitra Melia, N’guyen, Yohan, Neant, Nadège, Neb, Holger, Nekliudov, Nikita, Neto, Raul, Neumann, Emily, Neves, Bernardo, Ng, Pauline Yeung, Ng, Wing Yiu, Choileain, Orna Ni, Nichol, Alistair, Nonas, Stephanie, Noret, Marion, Norman, Lisa, Notari, Alessandra, Noursadeghi, Mahdad, Nowicka, Karolina, Nseir, Saad, Nunez, Jose, Nyamankolly, Elsa, O’donnell, Max, O’hearn, Katie, O’neil, Conar, Occhipinti, Giovanna, Ogston, Tawnya, Ogura, Takayuki, Oh, Tak-Hyuk, Ohshimo, Shinichiro, Oinam, Budha Charan Singh, Oliveira, Ana Pinho, Oliveira, João, Olliaro, Piero, Ong, David, Oosthuyzen, Wilna, Openshaw, Peter, Orozco-Chamorro, Claudia Milena, Orquera, Andrés, Osatnik, Javier, Ouamara, Nadia, Ouissa, Rachida, Owyang, Clark, Oziol, Eric, Póvoas, Diana, Pagadoy, Maïder, Pages, Justine, Palacios, Mario, Palmarini, Massimo, Panarello, Giovanna, Panda, Prasan Kumar, Panigada, Mauro, Pansu, Nathalie, Papadopoulos, Aurélie, Parra, Briseida, Pasquier, Jérémie, Patauner, Fabian, Patrão, Luís, Paul, Christelle, Paul, Mical, Paulos, Jorge, Paxton, William, Payen, Jean-François, Pearse, India, Peek, Giles, Peelman, Florent, Peiffer-Smadja, Nathan, Peigne, Vincent, Pejkovska, Mare, Peltan, Ithan, Pereira, Rui, Perez, Daniel, Perpoint, Thomas, Pesenti, Antonio, Petroušová, Lenka, Petrov-Sanchez, Ventzislava, Peytavin, Gilles, Pharand, Scott, Piagnerelli, Michael, Picard, Walter, Picone, Olivier, Piel-Julian, Marie, Pierobon, Carola, Pimentel, Carlos, Piroth, Lionel, Pius, Riinu, Piva, Simone, Plantier, Laurent, Plotkin, Daniel, Poissy, Julien, Pokorska-Spiewak, Maria, Poli, Sergio, Pollakis, Georgios, Popielska, Jolanta, Postma, Douwe, Povoa, Pedro, Powis, Jeff, Prapa, Sofia, Prebensen, Christian, Preiser, Jean-Charles, Prestre, Vincent, Price, Nicholas, Prinssen, Anton, Pritchard, Mark, Proença, Lúcia, Puéchal, Oriane, Purcell, Gregory, Quesada, Luisa, Quist-Paulsen, Else, Quraishi, Mohammed, Rätsep, Indrek, Rössler, Bernhard, Rabaud, Christian, Rafiq, Marie, Ragazzo, Gabrielle, Rainieri, Fernando, Ramakrishnan, Nagarajan, Ramanathan, Kollengode, Rammaert, Blandine, Rapp, Christophe, Rasmin, Menaldi, Rau, Cornelius, Rebaudet, Stanislas, Redl, Sarah, Reeve, Brenda, Reid, Liadain, Reis, Renato, Remppis, Jonathan, Remy, Martine, Renk, Hanna, Resende, Liliana, Resseguier, Anne-Sophie, Revest, Matthieu, Rewa, Oleksa, Reyes, Luis Felipe, Richardson, David, Richardson, Denise, Richier, Laurent, Riera, Jordi, Rios, Ana Lúcia, Rishu, Asgar, Rispal, Patrick, Risso, Karine, Nuñez, Maria Angelica Rivera, Rizer, Nicholas, Roberto, André, Roberts, Stephanie, Robertson, David, Robineau, Olivier, Roche-Campo, Ferran, Rodari, Paola, Rodeia, Simão, Abreu, Julia Rodriguez, Roilides, Emmanuel, Rojek, Amanda, Romaru, Juliette, Roncon-Albuquerque, Roberto, Roriz, Mélanie, Rosa-Calatrava, Manuel, Rose, Michael, Rosenberger, Dorothea, Rossanese, Andrea, Rossignol, Bénédicte, Rossignol, Patrick, Roy, Carine, Roze, Benoît, Russell, Clark, Ryckaert, Steffi, Holten, Aleksander Rygh, Choez, Xavier Sánchez, Saba, Isabela, Sadat, Musharaf, Saidani, Nadia, Salazar, Leonardo, Sales, Gabriele, Sallaberry, Stéphane, Salvator, Hélène, Sanchez-Miralles, Angel, Sanchez, Olivier, Sancho-Shimizu, Vanessa, Sandhu, Gyan, Sandulescu, Oana, Santos, Marlene, Sarfo-Mensah, Shirley, Sarton, Benjamine, Saviciute, Egle, Savvidou, Parthena, Scarsbrook, Joshua, Schermer, Tjard, Scherpereel, Arnaud, Schneider, Marion, Schroll, Stephan, Schwameis, Michael, Scott-Brown, James, Scott, Janet, Sedillot, Nicholas, Seitz, Tamara, Semaille, Caroline, Semple, Malcolm, Senneville, Eric, Sequeira, Filipa, Sequeira, Tânia, Shadowitz, Ellen, Shamsah, Mohammad, Sharma, Pratima, Shaw, Catherine, Shaw, Victoria, Shiban, Nisreen, Shime, Nobuaki, Shimizu, Hiroaki, Shimizu, Keiki, Shrapnel, Sally, Shum, Hoi Ping, Mohammed, Nassima Si, Sigfrid, Louise, Silva, Catarina, Silva, Maria Joao, Sin, Wai Ching, Skogen, Vegard, Smith, Sue, Smood, Benjamin, Smyth, Michelle, Snacken, Morgane, So, Dominic, Solis, Monserrat, Solomon, Joshua, Solomon, Tom, Somers, Emily, Sommet, Agnès, Song, Myung Jin, Song, Rima, Song, Tae, Sonntagbauer, Michael, Soum, Edouard, Uva, Maria Sousa, Sousa, Marta, Souza-Dantas, Vicente, Sperry, Alexandra, Sriskandan, Shiranee, Staudinger, Thomas, Stecher, Stephanie-Susanne, Stienstra, Ymkje, Stiksrud, Birgitte, Streinu-Cercel, Adrian, Streinu-Cercel, Anca, Strudwick, Samantha, Stuart, Ami, Stuart, David, Sultana, Asfia, Summers, Charlotte, Svistunov, Magdalena Surovcová Andrey A., Syrigos, Konstantinos, Sztajnbok, Jaques, Szuldrzynski, Konstanty, Téoulé, François, Tabrizi, Shirin, Tagherset, Lysa, Talarek, Ewa, Taleb, Sara, Talsma, Jelmer, Le Van, Tan, Tanaka, Hiroyuki, Tanaka, Taku, Taniguchi, Hayato, Tardivon, Coralie, Tattevin, Pierre, Taufik, M. Azhari, Tedder, Richard, Teixeira, João, Tellier, Marie-Capucine, Terpstra, Pleun, Terrier, Olivier, Terzi, Nicolas, Tessier-Grenier, Hubert, Thibault, V., Thiberville, Simon-Djamel, Thill, Benoît, Thompson, A., Thompson, Shaun, Thomson, David, Thomson, Emma, Thuy, Duong Bich, Thwaites, Ryan, Timashev, Peter, Timsit, Jean-François, Vijayaraghavan, Bharath Kumar Tirupakuzhi, Toki, Maria, Tonby, Kristian, Santos-Olmo, Rosario Maria Torres, Torres, Antoni, Torres, Margarida, Trioux, Théo, Trieu, Huynh Trung, Tromeur, Cécile, Trontzas, Ioannis, Troost, Jonathan, Trouillon, Tiffany, Tual, Christelle, Tubiana, Sarah, Tuite, Helen, Turtle, Lance, Twardowski, Pawel, Uchiyama, Makoto, Ullrich, Roman, Uribe, Alberto, Usman, Asad, Val-Flores, Luís, van de Velde, Stijn, van den Berge, Marcel, van Der Feltz, Machteld, van Der Vekens, Nicky, van Der Voort, Peter, van Der Werf, Sylvie, van Dyk, Marlice, van Gulik, Laura, van Hattem, Jarne, van Lelyveld, Steven, van Netten, Carolien, Vanel, Noémie, Vanoverschelde, Henk, Vauchy, Charline, Veislinger, Aurélie, Velazco, Jorge, Ventura, Sara, Verbon, Annelies, Vieira, César, Villanueva, Joy Ann, Villar, Judit, Villeneuve, Pierre-Marc, Villoldo, Andrea, van Vinh Chau, Nguyen, Visseaux, Benoit, Visser, Hannah, Vuorinen, Aapeli, Vuotto, Fanny, Wang, Chih-Hsien, Wei, Jia, Weil, Katharina, Wesselius, Sanne, Wham, Murray, Whelan, Bryan, White, Nicole, Wiedemann, Aurélie, Wille, Keith, Wils, Evert-Jan, Xynogalas, Ioannis, Suen, Jacky, Yacoub, Sophie, Yamazaki, Masaki, Yazdanpanah, Yazdan, Yelnik, Cécile, Yerkovich, Stephanie, Yokoyama, Toshiki, Yonis, Hodane, Young, Paul, Yuliarto, Saptadi, Zabbe, Marion, Zacharowski, Kai, Zahran, Maram, Zambon, Maria, Zanella, Alberto, Zawadka, Konrad, Zayyad, Hiba, Zoufaly, Alexander, Zucman, David, Abdukahil, S. A., Abe, R., Abel, L., Absil, L., Acker, A., Adachi, S., Adam, E., Adriao, D., Ainscough, K., Hssain, A. A., Tamlihat, Y. A., Akimoto, T., Al-Dabbous, T., Al-Fares, A., Al Qasim, E., Alalqam, R., Alex, B., Alexandre, K., Alfoudri, H., Alidjnou, K. E., Aliudin, J., Allavena, C., Allou, N., Alves, J., Alves, R., Amaral, M., Ammerlaan, H., Ampaw, P., Andini, R., Andrejak, C., Angheben, A., Angoulvant, F., Ansart, S., Antonelli, M., De Brito, C. A. A., Arabi, Y., Aragao, I., Arcadipane, A., Arenz, L., Arlet, J. -B., Arnold-Day, C., Arora, L., Artaud-Macari, E., Asensio, A., Assie, J. B., Atique, A., Auchabie, J., Aumaitre, H., Azemar, L., Azoulay, C., Bach, B., Bachelet, D., Baillie, J. K., Bak, E., Bakakos, A., Banisadr, F., Barbalho, R., Barclay, W. S., Barnikel, M., Barrelet, A., Barrigoto, C., Basmaci, R., Rincon, D. F. B., Bedossa, A., Behilill, S., Beljantsev, A., Bellemare, D., Beltrame, A., Beluze, M., Benech, N., Benkerrou, D., Bennett, S., Bento, L. I., Berdal, J. -E., Bergeaud, D., Bertolino, L., Bessis, S., Bevilcaqua, S., Bhavsar, K., Humaid, F. B., Bissuel, F., Biston, P., Bitker, L., Blanco-Schweizer, P., Blot, M., Boccia, F., Bogaert, D., Bompart, F., Booth, G., Borges, D., Borie, R., Bos, J., Bosse, H. M., Botelho-Nevers, E., Bouadma, L., Bouchaud, O., Bouchez, S., Bouhmani, D., Bouhour, D., Bouiller, K., Bouillet, L., Bouisse, C., Boureau, A. -S., Bouscambert, M., Bouziotis, J., Boxma, B., Boyer-Besseyre, M., Boylan, M., Braga, C., Brandenburger, T., Brazzi, L., Breen, D., Breen, P., Brickell, K., Brozzi, N., Buchtele, N., Buesaquillo, C., Bugaeva, P., Buisson, M., Burhan, E., Bustos, I. G., Butnaru, D., Carcel, S., Cabie, A., Cabral, S., Caceres, E., Callahan, M., Calligy, K., Calvache, J. A., Camoes, J., Campana, V., Campbell, P., Canepa, C., Cantero, M., Caraux-Paz, P., Cardoso, F., Cardoso, S., Carelli, S., Carlier, N., Carney, G., Carpenter, C., Carret, M. -C., Carrier, F. M., Carson, G., Casanova, M. -L., Cascao, M., Casimiro, J., Cassandra, B., Castaneda, S., Castanheira, N., Castor-Alexandre, G., Castrillon, H., Castro, I., Catarino, A., Catherine, F. -X., Cavalin, R., Cavalli, G. G., Cavayas, A., Ceccato, A., Cervantes-Gonzalez, M., Chair, A., Chakveatze, C., Chan, A., Chand, M., Chas, J., Chassin, C., Chen, A., Chen, Y. -S., Cheng, M. P., Cheret, A., Chiarabini, T., Chica, J., Chirouze, C., Chiumello, D., Cho, H. J., Cho, S. M., Cholley, B., Cidade, J. P., Herreros, J. M. C., Citarella, B. W., Ciullo, A., Clarke, J., Clohisey, S., Codan, C., Cody, C., Coelho, A., Colin, G., Collins, M., Colombo, S. M., Combs, P., Connelly, J. P., Connor, M., Conrad, A., Contreras, S., Cooke, G. S., Copland, M., Cordel, H., Corley, A., Cormican, S., Cornelis, S., Corpuz, A. J., Corvaisier, G., Couffignal, C., Couffin-Cadiergues, S., Courtois, R., D'Orleans, C. C., Croonen, S., Crowl, G., Crump, J., Cruz, C., Csete, M., Cucino, A., Cullen, C., Cummings, M., Curley, G., Curlier, E., Custodio, P., D'Aragon, F., Da Silva Filipe, A., Da Silveira, C., D'Ortenzio, E., Dabaliz, A. -A., Dagens, A. B., Dalton, H., Dalton, J., Daneman, N., Dankwa, E. A., Dantas, J., De Castro, N., De Mendoza, D., De Oliveira Franca, R. F., De Rosa, R., De Silva, T., De Vries, P., Dean, D., Debray, M. -P., Dechert, W., Deconninck, L., Decours, R., Delacroix, I., Delavigne, K., Deligiannis, I., Dell'Amore, A., Delobel, P., Demonchy, E., Denis, E., Deplanque, D., Depuydt, P., Desai, M., Descamps, D., Desvallee, M., Dewayanti, S. R., Diallo, A., Diamantis, S., Dias, A., Diaz, J. J. D., Diaz, R., Didier, K., Diehl, J. -L., Dieperink, W., Dimet, J., Dinot, V., Diouf, A., Dishon, Y., Djossou, F., Docherty, A. B., Dong, A., Donnelly, C. A., Donnelly, M., Donohue, C., Dorival, C., Douglas, J. J., Douma, R., Dournon, N., Downer, T., Downing, M., Drake, T., Dubee, V., Dubos, F., Ducancelle, A., Dudman, S., Dunning, J., Durante-Mangoni, E., Duranti, S., Durham, L., Dussol, B., Duval, X., Dyrhol-Riise, A. M., Eira, C., Vidal, J. E., Sanharawi, M. E., Elapavaluru, S., Elharrar, B., Elkheir, N., Ellerbroek, J., Ellis, R., Eloy, P., Elshazly, T., Enderle, I., Engelmann, I., Enouf, V., Epaulard, O., Esperatti, M., Esperou, H., Esposito-Farese, M., Estevao, J., Etienne, M., Ettalhaoui, N., Everding, A. G., Evers, M., Fabre, I., Faheem, A., Fahy, A., Fairfield, C. J., Faria, P., Farshait, N., Fatoni, A. Z., Faure, K., Fayed, M., Feely, N., Fernandes, J., Fernandes, M., Fernandes, S., Ferrao, J., Devouge, E. F., Ferraz, M., Ferreira, B., Ferrer-Roca, R., Figueiredo-Mello, C., Flateau, C., Fletcher, T., Florio, L. L., Foley, C., Fomin, V., Fonseca, C. D., Fonseca, T., Fontela, P., Forsyth, S., Foti, G., Fourn, E., Fowler, R., Franch-Llasat, D., Fraser, C., Fraser, J., Freire, M. V., Ribeiro, A. F., Friedrich, C., Fry, S., Fuentes, N., Fukuda, M., Gomez-Junyent, J., Gaborieau, V., Gachet, B., Gaci, R., Gagliardi, M., Gagnard, J. -C., Gagneux-Brunon, A., Gaiao, S., Gallagher, P., Curto, E. G., Gamble, C., Garan, A., Garcia-Gallo, E., Garcia, R., Garot, D., Garrait, V., Gault, N., Gavin, A., Gaymard, A., Gebauer, J., Morlaes, L. G., Germano, N., Ghosn, J., Giani, M., Giaquinto, C., Gibson, J., Gigante, T., Gilg, M., Giordano, G., Girvan, M., Gissot, V., Giwangkancana, G., Glikman, D., Glybochko, P., Gnall, E., Goco, G., Goehringer, F., Goepel, S., Goffard, J. -C., Golob, J., Gorenne, I., Goujard, C., Goulenok, T., Grable, M., Grandin, E. W., Granier, P., Grasselli, G., Green, C. A., Greenhalf, W., Greffe, S., Grieco, D. L., Griffee, M., Griffiths, F., Grigoras, I., Groenendijk, A., Lordemann, A. G., Gruner, H., Gu, Y., Guedj, J., Guellec, D., Guerguerian, A. -M., Guerreiro, D., Guery, R., Guillaumot, A., Guilleminault, L., Guimard, T., Haber, D., Hakak, S., Hall, M., Halpin, S., Hamer, A., Hamidfar, R., Hammond, T., Hardwick, H., Harley, K., Harrison, E. M., Harrison, J., Hays, L., Heerman, J., Heggelund, L., Hendry, R., Hennessy, M., Henriquez-Trujillo, A., Hentzien, M., Hernandez-Montfort, J., Hidayah, A., Higgins, D., Higgins, E., Hinton, S., Hipolito-Reis, A., Hiraiwa, H., Hiscox, J. A., Ho, A. Y. W., Hoctin, A., Hoffmann, I., Hoiting, O., Holt, R., Holter, J. C., Horby, P., Horcajada, J. P., Hoshino, K., Hough, C. L., Hsu, J. M. -Y., Hulot, J. -S., Ijaz, S., Illes, H. -G., Inacio, H., Dominguez, C. I., Iosifidis, E., Irvine, L., Isgett, S., Isidoro, T., Isnard, M., Itai, J., Ivulich, D., Jaafoura, S., Jabot, J., Jackson, C., Jamieson, N., Jaureguiberry, S., Javidfar, J., Jean-Benoit, Z., Jego, F., Jenum, S., Sotomayor, R. J., Garcia, R. N. J., Joseph, C., Joseph, M., Jouvet, P., Jung, H., Kafif, O., Kaguelidou, F., Kali, S., Kalomoiri, S., Kandamby, D. H., Kandel, C., Kant, R., Kartsonaki, C., Kasugai, D., Katz, K., Johal, S. K., Keating, S., Kelly, A., Kelly, S., Kennedy, L., Kennon, K., Kerroumi, Y., Kestelyn, E., Khalid, I., Khalil, A., Khan, C., Khan, I., Kho, M. E., Khoo, S., Kida, Y., Kiiza, P., Kildal, A. B., Kimmoun, A., Kindgen-Milles, D., Kitamura, N., Klenerman, P., Bekken, G. K., Knight, S., Kobbe, R., Vasconcelos, M. K., Korten, V., Kosgei, C., Krawczyk, K., Vecham, P. K., Kumar, D., Kurtzman, E., Kutsogiannis, D., Kyriakoulis, K., L'Her, E., Lachatre, M., Lacoste, M., Laffey, J. G., Lagrange, M., Laine, F., Lambert, M., Lamontagne, F., Langelot-Richard, M., Lantang, E. Y., Lanza, M., Laouenan, C., Laribi, S., Lariviere, D., Launay, O., Lavie-Badie, Y., Law, A., Le Bihan, C., Le Bris, C., Le Coustumier, E., Le Falher, G., Le Gac, S., Le Hingrat, Q., Le Marechal, M., Le Mestre, S., Le Moing, V., Le Nagard, H., Le Turnier, P., Leon, R., Le, M., Santos, M. L., Leal, E., Lee, J., Lee, S. H., Lee, T., Leeming, G., Lefebvre, B., Lefebvre, L., Lefevre, B., Lellouche, F., Lemaignen, A., Lemee, V., Lemmink, G., Leone, M., Lepiller, Q., Lescure, F. -X., Lesens, O., Lesouhaitier, M., Levy-Marchal, C., Levy, B., Levy, Y., Bassi, G. L., Liang, J., Lim, W. S., Lina, B., Lind, A., Lingas, G., Lion-Daolio, S., Liu, K., Loforte, A., Lolong, N., Lopes, D., Lopez-Colon, D., Loubet, P., Lucet, J. C., Luna, C. M., Lungu, O., Luong, L., Luton, D., Lyons, R., Muller, F., Muller, K. E., Maasikas, O., Macdonald, S., Machado, M., Macheda, G., Sanchez, J. M., Madhok, J., Mahieu, R., Mahy, S., Maier, L. S., Maillet, M., Maitre, T., Malfertheiner, M., Malik, N., Maltez, F., Malvy, D., Mambert, M., Manda, V., Mandei, J. M., Manning, E., Manuel, A., Sant, C. M., Malaque, A., Marino, F., De Araujo Mariz, C., Eid, C. M., Marques, A., Marquis, C., Marsh, B., Marsh, L., Marshall, J., Martelli, C. T., Martin-Blondel, G., Martin-Loeches, I., Martin-Quiros, A., Martin, D. -A., Martin, E., Martinot, M., Rego, C. M., Martins, A., Martins, J., Martucci, G., Marwali, E. M., Jimenez, J. F. M., Maslove, D., Mason, S., Matan, M., Mathieu, D., Mattei, M., Matulevics, R., Maulin, L., Mc Evoy, N., Mccarthy, A., Mccloskey, C., Mcconnochie, R., Mcdermott, S., Mcdonald, S., Mcelwee, S., Mcevoy, N., Mcgeer, A., Mcguinness, N., Mclean, K. A., Mcnicholas, B., Meaney, E., Mear-Passard, C., Mechlin, M., Mele, F., Menon, K., Mentre, F., Mentzer, A. J., Mercier, N., Merckx, A., Mergler, B., Merson, L., Mesquita, A., Meybeck, A., Meynert, A. M., Meyssonnier, V., Meziane, A., Mezidi, M., Michelanglei, C., Mihnovits, V., Maldonado, H. M., Mone, M., Moin, A., Molina, D., Molinos, E., Monteiro, A., Montes, C., Montrucchio, G., Moore, S., Moore, S. C., Morales-Cely, L., Moro, L., Tutillo, D. R. M., Motos, A., Mouquet, H., Perrot, C. M., Moyet, J., Mullaert, J., Munblit, D., Murphy, D., Murris, M., Myrodia, D. M., N'Guyen, Y., Neant, N., Neb, H., Nekliudov, N. A., Neto, R., Neumann, E., Neves, B., Ng, P. Y., Ng, W. Y., Choileain, O. N., Nichol, A., Nonas, S., Noret, M., Norman, L., Notari, A., Noursadeghi, M., Nowicka, K., Nseir, S., Nunez, J. I., Nyamankolly, E., O'Donnell, M., O'Hearn, K., O'Neil, C., Occhipinti, G., Ogston, T., Ogura, T., Oh, T. -H., Ohshimo, S., Oinam, B. C. S., Oliveira, A. P., Oliveira, J., Olliaro, P., Ong, D. S. Y., Oosthuyzen, W., Openshaw, P. J. M., Orozco-Chamorro, C. M., Orquera, A., Osatnik, J., Ouamara, N., Ouissa, R., Owyang, C., Oziol, E., Povoas, D., Pagadoy, M., Pages, J., Palacios, M., Palmarini, M., Panarello, G., Panda, P. K., Panigada, M., Pansu, N., Papadopoulos, A., Parra, B., Pasquier, J., Patauner, F., Patrao, L., Paul, C., Paul, M., Paulos, J., Paxton, W. A., Payen, J. -F., Pearse, I., Peek, G. J., Peelman, F., Peiffer-Smadja, N., Peigne, V., Pejkovska, M., Peltan, I. D., Pereira, R., Perez, D., Perpoint, T., Pesenti, A., Petrousova, L., Petrov-Sanchez, V., Peytavin, G., Pharand, S., Piagnerelli, M., Picard, W., Picone, O., Piel-Julian, M., Pierobon, C., Pimentel, C., Piroth, L., Pius, R., Piva, S., Plantier, L., Plotkin, D., Poissy, J., Pokorska-Spiewak, M., Poli, S., Pollakis, G., Popielska, J., Postma, D. F., Povoa, P., Powis, J., Prapa, S., Prebensen, C., Preiser, J. -C., Prestre, V., Price, N., Prinssen, A., Pritchard, M. G., Proenca, L., Puechal, O., Purcell, G., Quesada, L., Quist-Paulsen, E., Quraishi, M., Ratsep, I., Rossler, B., Rabaud, C., Rafiq, M., Ragazzo, G., Rainieri, F., Ramakrishnan, N., Ramanathan, K., Rammaert, B., Rapp, C., Rasmin, M., Rau, C., Rebaudet, S., Redl, S., Reeve, B., Reid, L., Reis, R., Remppis, J., Remy, M., Renk, H., Resende, L., Resseguier, A. -S., Revest, M., Rewa, O., Reyes, L. F., Richardson, D., Richier, L., Riera, J., Rios, A. L., Rishu, A., Rispal, P., Risso, K., Nunez, M. A. R., Rizer, N., Roberto, A., Roberts, S., Robertson, D. L., Robineau, O., Roche-Campo, F., Rodari, P., Rodeia, S., Abreu, J. R., Roilides, E., Rojek, A., Romaru, J., Roncon-Albuquerque, R., Roriz, M., Rosa-Calatrava, M., Rose, M., Rosenberger, D., Rossanese, A., Rossignol, B., Rossignol, P., Roy, C., Roze, B., Russell, C. D., Ryckaert, S., Holten, A. R., Choez, X. S., Saba, I., Sadat, M., Saidani, N., Salazar, L., Sales, G., Sallaberry, S., Salvator, H., Sanchez-Miralles, A., Sanchez, O., Sancho-Shimizu, V., Sandhu, G., Sandulescu, O., Santos, M., Sarfo-Mensah, S., Sarton, B., Saviciute, E., Savvidou, P., Scarsbrook, J., Schermer, T., Scherpereel, A., Schneider, M., Schroll, S., Schwameis, M., Scott-Brown, J., Scott, J. T., Sedillot, N., Seitz, T., Semaille, C., Semple, M. G., Senneville, E., Sequeira, F., Sequeira, T., Shadowitz, E., Shamsah, M., Sharma, P., Shaw, C. A., Shaw, V., Shiban, N., Shime, N., Shimizu, H., Shimizu, K., Shrapnel, S., Shum, H. P., Mohammed, N. S., Sigfrid, L., Silva, C., Silva, M. J., Sin, W. C., Skogen, V., Smith, S., Smood, B., Smyth, M., Snacken, M., So, D., Solis, M., Solomon, J., Solomon, T., Somers, E., Sommet, A., Song, M. J., Song, R., Song, T., Sonntagbauer, M., Soum, E., Uva, M. S., Sousa, M., Souza-Dantas, V., Sperry, A., Sriskandan, S., Staudinger, T., Stecher, S. -S., Stienstra, Y., Stiksrud, B., Streinu-Cercel, A., Strudwick, S., Stuart, A., Stuart, D., Sultana, A., Summers, C., Svistunov, M. S. A. A., Syrigos, K., Sztajnbok, J., Szuldrzynski, K., Teoule, F., Tabrizi, S., Tagherset, L., Talarek, E., Taleb, S., Talsma, J., Le Van, T., Tanaka, H., Tanaka, T., Taniguchi, H., Tardivon, C., Tattevin, P., Taufik, M. A., Tedder, R. S., Teixeira, J., Tellier, M. -C., Terpstra, P., Terrier, O., Terzi, N., Tessier-Grenier, H., Thibault, V., Thiberville, S. -D., Thill, B., Thompson, A. A. R., Thompson, S., Thomson, D., Thomson, E. C., Thuy, D. B., Thwaites, R. S., Timashev, P. S., Timsit, J. -F., Vijayaraghavan, B. K. T., Toki, M., Tonby, K., Santos-Olmo, R. M. T., Torres, A., Torres, M., Trioux, T., Trieu, H. T., Tromeur, C., Trontzas, I., Troost, J., Trouillon, T., Tual, C., Tubiana, S., Tuite, H., Turtle, L. C. W., Twardowski, P., Uchiyama, M., Ullrich, R., Uribe, A., Usman, A., Val-Flores, L., Van De Velde, S., Van Den Berge, M., Van Der Feltz, M., Van Der Vekens, N., Van Der Voort, P., Van Der Werf, S., Van Dyk, M., Van Gulik, L., Van Hattem, J., Van Lelyveld, S., Van Netten, C., Vanel, N., Vanoverschelde, H., Vauchy, C., Veislinger, A., Velazco, J., Ventura, S., Verbon, A., Vieira, C., Villanueva, J. A., Villar, J., Villeneuve, P. -M., Villoldo, A., Van Vinh Chau, N., Visseaux, B., Visser, H., Vuorinen, A., Vuotto, F., Wang, C. -H., Wei, J., Weil, K., Wesselius, S., Wham, M., Whelan, B., White, N., Wiedemann, A., Wille, K., Wils, E. -J., Xynogalas, I., Suen, J. Y., Yacoub, S., Yamazaki, M., Yazdanpanah, Y., Yelnik, C., Yerkovich, S., Yokoyama, T., Yonis, H., Young, P., Yuliarto, S., Zabbe, M., Zacharowski, K., Zahran, M., Zambon, M., Zanella, A., Zawadka, K., Zayyad, H., Zoufaly, A., Zucman, D., Apollo - University of Cambridge Repository, Human genetics of infectious diseases: Complex predisposition (Equipe Inserm U1163), Imagine - Institut des maladies génétiques (IHU) (Imagine - U1163), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Department of Mathematics and Statistics, Wichita State University, Service d'Anésthésie Réanimation [CHU Clermont-Ferrand], CHU Estaing [Clermont-Ferrand], CHU Clermont-Ferrand-CHU Clermont-Ferrand, Laboratoire Chrono-environnement (UMR 6249) (LCE), Centre National de la Recherche Scientifique (CNRS)-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Institut Pasteur [Paris] (IP), Génétique Moléculaire des Virus à ARN - Molecular Genetics of RNA Viruses (GMV-ARN (UMR_3569 / U-Pasteur_2)), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), This work was supported by the Department for International Development and Wellcome Trust [215091/Z/18/Z], the Bill and Melinda Gates Foundation [OPP1209135]. Country-specific support was provided by the Canadian Institutes of Health Research Coronavirus Rapid Research Funding Opportunity [OV2170359], the Health Research Board Ireland [CTN Award 2014-012], National Institute for Health Research (NIHR) [award CO-CIN-01], the Medical Research Council (MRC) [grant MC_PC_19059], the NIHR Health Protection Research Unit (HPRU) in Emerging and Zoonotic Infections at University of Liverpool in partnership with Public Health England (PHE), in collaboration with Liverpool School of Tropical Medicine and the University of Oxford [award 200907], NIHR HPRU in Respiratory Infections at Imperial College London with PHE [award 200927], Liverpool Experimental Cancer Medicine Centre [grant reference C18616/A25153], NIHR Biomedical Research Centre at Imperial College London [IS-BRC-1215-20013], EU Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE) [FP7 project 602525], National Institutes of Health (NIH) [UL1TR002240], and NIHR Clinical Research Network infrastructure support. We acknowledge the generous support of all ISARIC Partners who have contributed data and expertise to this analysis, with or without dedicated funding. The views expressed are those of the authors and not necessarily those of the funders or institutions listed above., European Project: 602525,EC:FP7:HEALTH,FP7-HEALTH-2013-INNOVATION-1,PREPARE(2014), Infectious diseases, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), Laboratoire Chrono-environnement - CNRS - UBFC (UMR 6249) (LCE), Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM), Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Medical Research Council (MRC), National Institute for Health Research, UKRI MRC COVID-19 Rapid Response Call, UK Research and Innovation, and BOZEC, Erwan
Subjects: Male, Abdominal pain, Pediatrics, 030204 cardiovascular system & hematology, Logistic regression, 0302 clinical medicine, Diagnosis, wc_505, Medicine, ISARIC Clinical Characterisation Group, Prospective Studies, 030212 general & internal medicine, Child, wa_105, COVID-19, Case definition, SARS-CoV-2, Symptoms, Aged, Female, Hospitalization, Hospitals, Humans, Middle Aged, General Medicine, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, 3. Good health, Infectious Diseases, Cohort, Vomiting, qw_160, medicine.symptom, Life Sciences & Biomedicine, Diagnosi, Human, Microbiology (medical), medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Nausea, Symptom, Age and sex, Microbiology, 1117 Public Health and Health Services, 03 medical and health sciences, Hospital, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Science & Technology, business.industry, 1103 Clinical Sciences, Prospective Studie, Observational study, wf_100, business
Abstract: Background The ISARIC prospective multinational observational study is the largest cohort of hospitalized patients with COVID-19. We present relationships of age, sex, and nationality to presenting symptoms. Methods International, prospective observational study of 60 109 hospitalized symptomatic patients with laboratory-confirmed COVID-19 recruited from 43 countries between 30 January and 3 August 2020. Logistic regression was performed to evaluate relationships of age and sex to published COVID-19 case definitions and the most commonly reported symptoms. Results ‘Typical’ symptoms of fever (69%), cough (68%) and shortness of breath (66%) were the most commonly reported. 92% of patients experienced at least one of these. Prevalence of typical symptoms was greatest in 30- to 60-year-olds (respectively 80, 79, 69%; at least one 95%). They were reported less frequently in children (≤ 18 years: 69, 48, 23; 85%), older adults (≥ 70 years: 61, 62, 65; 90%), and women (66, 66, 64; 90%; vs. men 71, 70, 67; 93%, each P Interpretation This international collaboration has allowed us to report reliable symptom data from the largest cohort of patients admitted to hospital with COVID-19. Adults over 60 and children admitted to hospital with COVID-19 are less likely to present with typical symptoms. Nausea and vomiting are common atypical presentations under 30 years. Confusion is a frequent atypical presentation of COVID-19 in adults over 60 years. Women are less likely to experience typical symptoms than men.
Published: 2021

7. Association of pediatric cardiac surgery-associated acute kidney injury with post-discharge healthcare utilization, mortality and kidney outcomes.

Author: Nunes, Sophia, Hessey, Erin, Dorais, Marc, Perreault, Sylvie, Jouvet, Philippe, Phan, Véronique, Lacroix, Jacques, Lafrance, Jean-Philippe, Samuel, Susan, and Zappitelli, Michael
Subjects: HYPERTENSION risk factors, MORTALITY risk factors, CARDIAC surgery, CHRONIC kidney failure, CONFIDENCE intervals, PEDIATRICS, SURGICAL complications, RETROSPECTIVE studies, MEDICAL care use, POSTOPERATIVE period, DESCRIPTIVE statistics, DATA analysis software, ACUTE kidney failure, LONGITUDINAL method, PROPORTIONAL hazards models, DISEASE risk factors, CHILDREN
Abstract: Background: Acute kidney Injury (AKI) in children undergoing cardiac surgery (CS) is strongly associated with hospital morbidity. Post-discharge CS AKI outcomes are less clear. We evaluated associations between AKI and post-discharge (a) healthcare utilization, (b) chronic kidney disease (CKD) or hypertension and (c) mortality. Methods: This is a retrospective two-centre cohort study of children surviving to hospital discharge after CS. Primary exposures were post-operative ≥Stage 1 AKI and ≥Stage 2 AKI defined by Kidney Disease Impoving Global Outcomes. Association of AKI with time to outcomes was determined using multivariable Cox-Proportional Hazards analysis. Results: Of 350 participants included (age 3.1 (4.5) years), 180 [51.4%] developed AKI and 60 [17.1%] developed ≥Stage 2 AKI. Twenty-eight (9%) participants developed CKD or hypertension (composite outcome), and 17 (5%) died within 5 years of discharge. Post-operative ≥Stage 1 and ≥Stage 2 AKI were not associated with post-discharge hospitalizations, emergency room (ER) visits, physician visits or CKD or hypertension in adjusted analyses. A trend was observed between ≥Stage 2 AKI and mortality but was not statistically significant. In unadjusted stratified analyses, AKI was associated with post-discharge hospitalizations in children with RACHS-1 score ≥3, complex chronic disease classification and children living in urban areas. Conclusions: Post-CS AKI is not associated with post-discharge healthcare utilization, death and CKD or hypertension, though it may be associated with healthcare utilization in more complex paediatric CS children. Studies should aim to better understand post-CS healthcare utilization patterns and non-AKI risk factors for CKD, hypertension and mortality, to reduce adverse long-term outcomes after CS. [ABSTRACT FROM AUTHOR]
Published: 2021
Full Text: View/download PDF

8. Validation process of a high‐resolution database in a paediatric intensive care unit—Describing the perpetual patient's validation.

Author: Mathieu, Audrey, Sauthier, Michael, Jouvet, Philippe, Emeriaud, Guillaume, and Brossier, David
Subjects: INTENSIVE care units, DATABASES, DATA quality, RESEARCH methodology, VITAL signs, PEDIATRICS, DATABASE management, LONGITUDINAL method, VIDEO recording
Abstract: Rationale: High data quality is essential to ensure the validity of clinical and research inferences based on it. However, these data quality assessments are often missing even though these data are used in daily practice and research. Aims and objectives: Our objective was to evaluate the data quality of our high‐resolution electronic database (HRDB) implemented in our paediatric intensive care unit (PICU). Methods We conducted a prospective validation study of a HRDB in a 32‐bed paediatric medical, surgical, and cardiac PICU in a tertiary care freestanding maternal‐child health centre in Canada. All patients admitted to the PICU with at least one vital sign monitored using a cardiorespiratory monitor connected to the central monitoring station. Results: Between June 2017 and August 2018, data from 295 patient days were recorded from medical devices and 4645 data points were video recorded and compared to the corresponding data collected in the HRDB. Statistical analysis showed an excellent overall correlation (R2 = 1), accuracy (100%), agreement (bias = 0, limits of agreement = 0), completeness (2% missing data), and reliability (ICC = 1) between recorded and collected data within clinically significant pre‐defined limits of agreement. Divergent points could all be explained. Conclusions: This prospective validation of a representative sample showed an excellent overall data quality. [ABSTRACT FROM AUTHOR]
Published: 2021
Full Text: View/download PDF

9. Quantitative Assessment of Spontaneous Breathing in Children: Evaluation of a Depth Camera System.

Author: Rehouma, Haythem, Noumeir, Rita, Essouri, Sandrine, and Jouvet, Philippe
Subjects: CRITICALLY ill children, PEDIATRIC intensive care, RESPIRATION, THREE-dimensional imaging, INTENSIVE care units, CAMERAS, VIDEOS
Abstract: This article describes a new approach for quantitative evaluation of respiration in the pediatric intensive care unit (PICU). Video sequences of thorax movements are recorded by two depth cameras to cover the 3-D surface of the torso and its lateral sides. The breathing activity implies a frame-by-frame surface deformation, which can be described by the volume variation of reconstructed surfaces between the consecutive video frames. A quantitative evaluation of the breathing pattern is then performed through a subtraction technique, thereby detecting the volume variation between the subsequent frames. A high-fidelity simulation was performed in a realistic environment designed for critically ill children. The simulation was then followed by a real-world evaluation, involving two newborn babies (one female and one male) who required ventilator support. The breathing signal patterns resulting from our approach were compared to those measured by mechanical ventilation in terms of their waveforms, evaluating the most significant dynamic parameters: tidal volume, respiratory rate, and minute ventilation. Our experimental study showed a significant agreement between the proposed 3-D imaging system and the gold standard method in estimating respiratory waveforms and parameters. This article presents the following innovations. First, we suggest a 3-D imaging system specifically designed for PICUs based on a contactless design. Second, we propose an efficient positioning mechanism for the cameras, offering a very high spatial coverage of the thoracoabdominal zone and considering the PICU constraints. Finally, we propose an objective vision-based method to quantitatively measure respiration for spontaneous breathing patients in PICUs. [ABSTRACT FROM AUTHOR]
Published: 2020
Full Text: View/download PDF

10. Qualitative subjective assessment of a high‐resolution database in a paediatric intensive care unit—Elaborating the perpetual patient's ID card.

Author: Brossier, David, Sauthier, Michael, Mathieu, Audrey, Goyer, Isabelle, Emeriaud, Guillaume, and Jouvet, Philippe
Subjects: DATABASES, DATABASE evaluation, HEALTH, IDENTIFICATION, INTENSIVE care units, MEDICAL students, PATIENTS, PEDIATRICS, QUALITATIVE research, INFORMATION professionals, DESCRIPTIVE statistics, EVALUATION
Abstract: Objective: The main purpose of our study was to subjectively assess the quality of a paediatric intensive care unit (PICU) database according to the Directory of Clinical Databases (DoCDat) criteria. Design and setting: A survey was conducted between April 1 and June 15, 2018, among the Sainte Justine PICU research group. Population: Every member of this group whose research activity required the use of the database and/or who was involved in the development/validation of the database. Interventions: None. Measurements and main results: All 10 research team members (one Information Technology specialist, one junior medical student, and eight clinician researchers) who used the high‐resolution database fulfilled the survey (100% response rate). The median quality level of the Sainte Justine PICU database across all the 10 criteria was 3 (2‐4), rated on a 1 (worst) to 4 (best) numeric scale. When compared with previously assessed databases through the DoCDat criteria, we found that the Sainte Justine PICU database performance was similar. Conclusions: The PICU high‐resolution database appeared of good quality when subjectively assessed by the DoCDat criteria. Further validation procedures are mandatory. We suggest that data quality assessment and validation procedures should be reported when creating a new database. [ABSTRACT FROM AUTHOR]
Published: 2020
Full Text: View/download PDF

11. Intérêt de la ventilation non invasive en réanimation pédiatrique : doit-on espérer un autre niveau de preuve ? Non-invasive ventilation in children: Do we need more evidence?

Author: mortamet, guillaume, Emeriaud, Guillaume, Jouvet, Philippe, Fauroux, Brigitte, Essouri, Sandrine, Soins intensifs pédiatriques [CHU Sainte -Justine Montréal], Université de Montréal (UdeM)-CHU Sainte Justine [Montréal], Biomécanique et appareil respiratoire : une approche multi-échelles (Equipe 13), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Service d'assistance respiratoire et sommeil de l'enfant [CHU Necker], CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département de Pédiatrie [CHU Sainte -Justine Montréal], CHU Sainte Justine [Montréal], mortamet, guillaume, Biomécanique cellulaire et respiratoire (BCR), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-Centre National de la Recherche Scientifique (CNRS), and Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12)-IFR10
Subjects: [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, [SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics, pediatrics, noninvasive ventilation, mechanical ventilation
Abstract: International audience; La ventilation non invasive (VNI) permet de s’affranchir de certains effets inde ́ sirables de la ventilation invasive, de diminuer la dure ́ e d’hospitalisation et ame ́liore la survie de certains patients. L’impor- tance de l’utilisation de la VNI en pratique courante contraste avec le manque d’e ́ tudes prospectives ou d’e ́ tudes randomise ́ es controˆ le ́ es pe ́diatriques dans ce domaine. L’objectif de cette revue est de recenser les principales indications de VNI de courte dure ́e en re ́ animation pe ́ diatrique : bronchiolite, de ́ tresse respiratoire apre` s extubation, syndrome de de ́ tresse respiratoire aigue ̈ , pneumopathie aigue ̈ , asthme aigu grave, syndrome thoracique aigu, de ́ compensa- tion cardiaque gauche, de ́compensation d’une insuffisance respira- toire chronique, obstruction des voies ae ́ riennes supe ́ rieures et soins de support. La plupart de ces indications reposent sur des donne ́es descriptives et des opinions d’experts, peu e ́tant issues d’essais randomise ́ s. Alors que le be ́ ne ́ fice de la VNI est e ́ vident dans certaines indications, comme la bronchiolite, il est plus discutable dans d’autres. La surveillance des patients et de marqueurs d’e ́chec est donc capitale.
Published: 2016

12. Impact of Spontaneous Breathing Trial on Work of Breathing Indices Derived From Esophageal Pressure, Electrical Activity of the Diaphragm, and Oxygen Consumption in Children.

Author: Mortamet, Guillaume, Nardi, Nicolas, Groleau, Véronique, Essouri, Sandrine, Fauroux, Brigitte, Jouvet, Philippe, and Emeriaud, Guillaume
Subjects: DIAPHRAGM physiology, ESOPHAGEAL physiology, RESPIRATORY muscle physiology, ANALYSIS of variance, ARTIFICIAL respiration, CALORIMETRY, CHI-squared test, STATISTICAL correlation, CRITICALLY ill, FISHER exact test, INTENSIVE care units, LONGITUDINAL method, PATIENTS, PEDIATRICS, RESEARCH funding, RESPIRATION, T-test (Statistics), MECHANICAL ventilators, RELATIVE medical risk, PRE-tests & post-tests, CONTINUING education units, REPEATED measures design, OXYGEN consumption, DATA analysis software, DESCRIPTIVE statistics, POSITIVE end-expiratory pressure, MANN Whitney U Test, CHILDREN
Abstract: BACKGROUND: The present study aimed to characterize the behavior of 3 components of respiratory muscle function during mechanical ventilation weaning in children to better understand the respective impact of a spontaneous breathing trial on ventilatory mechanical action (esophageal pressure [Pes], ventilatory demand (electrical activity of the diaphragm [EAdi]), and oxygen consumption. METHODS: This was a prospective single-center study. All children > 1 months and <18 y old who were intubated and on mechanical ventilation, and who were hospitalized in the pediatric ICU were eligible. Subjects considered as ready to extubate were included. Simultaneous recordings of oxygen consumption, Pes, and EAdi were performed during 3 steps: before, during, and after the spontaneous breathing test. RESULTS: Twenty subjects (median age, 5.5 mo) were included. Half of them were admitted for a respiratory cause. The increase in Pes swings and esophageal pressure-time product during the spontaneous breathing trial was not significant (P = .33 and P = .75, respectively), and a similar trend was observed with peak EAdi (P = .06). Oxygen consumption obtained by indirect calorimetry was stable in the 3 conditions (P = .98). CONCLUSIONS: In these children who were critically ill, a spontaneous breathing trial induced a moderate and nonsignificant increase in work of breathing, as reflected by the respiratory drive with EAdi and respiratory mechanics with Pes. However, indirect calorimetry did not seem to be a sensitive tool to assess respiratory muscle function during the weaning phase in children who were on mechanical ventilation, especially when work of breathing was slightly increased. [ABSTRACT FROM AUTHOR]
Published: 2019
Full Text: View/download PDF

13. Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit.

Author: Brossier, David, Goyer, Isabelle, Ziani, Lydia, Marquis, Christopher, Mitchell, Grant, Ozanne, Bruno, and Jouvet, Philippe
Abstract: The purpose of the study was to evaluate the influence of establishing a protocol for the use of combined sodium benzoate and sodium phenylacetate (SBSP) (Ammonul®) to treat acute hyperammonemia. This was a retrospective, single‐center study in a 24‐bed medical and surgical pediatric intensive care unit (PICU) in a tertiary care teaching maternal–child hospital in Canada. Inclusion criteria were age < 18 years, PICU admission between 1 January 2000 and 30 June 2016, and SBSP treatment. An SBSP delivery protocol was implemented in our hospital on 30 August 2008 in order to improve management of acute hyperammonemia. Patients were assigned to one of the two groups, without or with protocol, depending on date of admission. SBSP was ordered 34 times during the study period, and 23 orders were considered for analysis (14 with and 9 without protocol). Patient characteristics were similar between groups. The median time from diagnosis to prescription was significantly shorter in the protocol group [40 min (21–82) vs 100 min (70–150), p = 0.03)] but the median time from diagnosis to administration of the treatment was equivalent [144 min (90–220) vs 195 (143–274), (p = 0.2)]. Other clinical outcomes did not differ. This study is the first to compare two SBSP delivery strategies in the treatment of acute hyperammonemia in this PICU setting. Implementation of a delivery protocol shortened the time from diagnosis of hyperammonemia to prescription of SBSP and helped us identify other parameters that can be improved to optimize treatment delivery. [ABSTRACT FROM AUTHOR]
Published: 2019
Full Text: View/download PDF

14. When the Children Control the Ventilator, They Adopt an Appropriate Ventilation with a Strict Control of Blood pH.

Author: Veillet, Marie-Pier, Sauthier, Michael, Frigon, Claudia, Ducruet, Thierry, Jouvet, Philippe, and Emeriaud, Guillaume
Subjects: BLOOD pH, P-value (Statistics), MECHANICAL ventilators, ARTIFICIAL respiration equipment, DIAPHRAGM physiology, INTENSIVE care units, RESEARCH, RESPIRATORY insufficiency, BLOOD gases analysis, HYDROGEN-ion concentration, RESEARCH methodology, PEDIATRICS, EVALUATION research, MEDICAL cooperation, SELF medication, ARTIFICIAL respiration, COMPARATIVE studies, RESPIRATORY mechanics
Published: 2019
Full Text: View/download PDF

15. Acute pediatric hyperammonemia: current diagnosis and management strategies.

Author: Savy, Nadia, Brossier, David, Brunel-Guitton, Catherine, Ducharme-Crevier, Laurence, Pont-Thibodeau, Geneviève Du, and Jouvet, Philippe
Abstract: Acute hyperammonemia may induce a neurologic impairment leading to an acute life-threatening condition. Coma duration, ammonia peak level, and hyperammonemia duration are the main risk factors of hyperammonemia-related neurologic deficits and death. In children, hyperammonemia is mainly caused by severe liver failure and inborn errors of metabolism. In an acute setting, obtaining reliable plasma ammonia levels can be challenging because of the preanalytical difficulties that need to be addressed carefully. The management of hyperammonemia includes 1) identification of precipitating factors and cerebral edema presence, 2) a decrease in ammonia production by reducing protein intake and reversing catabolism, and 3) ammonia removal with pharmacologic treatment and, in the most severe cases, with extracorporeal therapies. In case of severe coma, transcranial Doppler ultrasound could be the method of choice to noninvasively monitor cerebral blood flow and titrate therapies. [ABSTRACT FROM AUTHOR]
Published: 2018
Full Text: View/download PDF

16. Patient-ventilator asynchrony during conventional mechanical ventilation in children.

Author: Mortamet, Guillaume, Larouche, Alexandrine, Ducharme-Crevier, Laurence, Fléchelles, Olivier, Constantin, Gabrielle, Essouri, Sandrine, Pellerin-Leblanc, Amélie-Ann, Beck, Jennifer, Sinderby, Christer, Jouvet, Philippe, and Emeriaud, Guillaume
Subjects: ARTIFICIAL respiration, CRITICALLY ill children, DIAPHRAGM (Anatomy), PEDIATRIC intensive care, PATIENT-ventilator dyssynchrony, MEDICAL care
Abstract: Background: We aimed (1) to describe the characteristics of patient-ventilator asynchrony in a population of critically ill children, (2) to describe the risk factors associated with patient-ventilator asynchrony, and (3) to evaluate the association between patient-ventilator asynchrony and ventilator-free days at day 28. Methods: In this single-center prospective study, consecutive children admitted to the PICU and mechanically ventilated for at least 24 h were included. Patient-ventilator asynchrony was analyzed by comparing the ventilator pressure curve and the electrical activity of the diaphragm (Edi) signal with (1) a manual analysis and (2) using a standardized fully automated method. Results: Fifty-two patients (median age 6 months) were included in the analysis. Eighteen patients had a very low ventilatory drive (i.e., peak Edi < 2 µV on average), which prevented the calculation of patient-ventilator asynchrony. Children spent 27% (interquartile 22-39%) of the time in conflict with the ventilator. Cycling-off errors and trigger delays contributed to most of this asynchronous time. The automatic algorithm provided a NeuroSync index of 45%, confirming the high prevalence of asynchrony. No association between the severity of asynchrony and ventilator-free days at day 28 or any other clinical secondary outcomes was observed, but the proportion of children with good synchrony was very low. Conclusion: Patient-ventilator interaction is poor in children supported by conventional ventilation, with a high frequency of depressed ventilatory drive and a large proportion of time spent in asynchrony. The clinical benefit of strategies to improve patient-ventilator interactions should be evaluated in pediatric critical care. [ABSTRACT FROM AUTHOR]
Published: 2017
Full Text: View/download PDF

17. 2009–2010 Influenza A(H1N1)-related critical illness among Aboriginal and non-Aboriginal Canadians.

Author: Jung, James J., Pinto, Ruxandra, Zarychanski, Ryan, Cook, Deborah J., Jouvet, Philippe, Marshall, John C., Kumar, Anand, Long, Jennifer, Rodin, Rachel, Fowler, Robert A., and null, null
Subjects: H1N1 influenza, CATASTROPHIC illness, ANTIVIRAL agents, LOGISTIC regression analysis, PATIENTS, THERAPEUTICS
Abstract: Background: Preliminary studies suggested that Aboriginal Canadians had disproportionately higher rates of infection, hospitalization, and critical illness due to pandemic Influenza A(H1N1)pdm09. Methods: We used a prospective cohort study of critically ill patients with laboratory confirmed or probable H1N1 infection in Canada between April 16 2009 and April 12 2010. Baseline characteristics, medical interventions, clinical course and outcomes were compared between Aboriginal and non-Aboriginal patients. The primary outcome was hospital mortality. Results: Of 647 critically ill adult patients with known ethnicity, 81 (12.5%) were Aboriginal, 566 (87.5%) were non-Aboriginal. Aboriginal patients were younger (mean [SD] age 40.7[13.7] v. 49.0[14.9] years, p < 0.001) and more frequently female (64.2% v. 51.1%, p = 0.027). Rates of any co-morbid illnesses (Aboriginal v. non-Aboriginal, 92.6% v. 91.0%, p = 0.63), time from symptom onset to hospital admission (median [interquartile range] 4 [2–7] v. 4 [2–7] days, p = 0.84), time to ICU admission (5 [3–8] v.5 [3–8] days, p = 0.91), and severity of illness (mean APACHE II score (19.9 [9.6] v. 21.1 [9.9], p = 0.33) were similar. A similar proportion of Aboriginal patients received antiviral medication before ICU admission than non-Aboriginal patients (91.4% v. 93.8%, p = 0.40). Among Aboriginal versus non-Aboriginal patients, the need for mechanical ventilation (93.8% v. 88.6%, p = 0.15), ventilator-free days (14 [3–23] v. 17 [0–24], p = 0.62), durations of stay in ICU (13[7-19.5] v. 11 [5–8] days, p = 0.05), hospital (19 [12.5-33.5] v. 18 [11-35] days, p = 0.63), and hospital mortality were similar (19.8% v. 22.6%, p = 0.56). In multiple logistic regression analyses, higher APACHE II score (1.06; 1.04-1.09, p<0.001) was independently associated with an increased risk of death; antiviral treatment with a lower risk of death (0.34; 0.15 – 0.78, p = 0.01). Ethnicity was not associated with mortality. Interpretation: During the 2009-2010 Influenza A (H1N1) pandemic, Aboriginal and non-Aboriginal Canadians with H1N1-related critical illness had a similar risk of death, after adjusting for potential confounding factors. [ABSTRACT FROM AUTHOR]
Published: 2017
Full Text: View/download PDF

18. Modalities and Complications Associated With the Use of High-Flow Nasal Cannula: Experience in a Pediatric ICU.

Author: Baudin, Florent, Gagnon, Sebastien, Crulli, Benjamin, Proulx, François, Jouvet, Philippe, and Emeriaud, Guillaume
Subjects: PNEUMOTHORAX, PNEUMOMEDIASTINUM, NOSEBLEED, ARTIFICIAL respiration, BLOOD gases analysis, CHEST X rays, CHI-squared test, CONFIDENCE intervals, INTENSIVE care units, NITRIC oxide, SCIENTIFIC observation, PEDIATRICS, PROBABILITY theory, STATISTICS, DATA analysis, RETROSPECTIVE studies, CHEST tubes, DATA analysis software, ELECTRONIC health records, DESCRIPTIVE statistics, NASAL cannula, FRIEDMAN test (Statistics), DIAGNOSIS
Abstract: BACKGROUND: High-flow nasal cannula (HFNC) therapy is increasingly used in pediatric ICUs as an intermediate level of support between conventional oxygen delivery and noninvasive ventilation (NIV). The safety of HFNC has seldom been studied, and some cases of barotrauma have been reported. This retrospective study aims to describe HFNC use in a tertiary care pediatric ICU, with a focus on the complications associated with this therapy. METHODS: Between January 2013 and January 2014, all children <18 y old treated with HFNC in the pediatric ICU were included. Demographic data, HFNC settings, chest radiograph reports, and blood gas values were gathered from the electronic medical records. Episodes of pneumothorax, pneumomediastinum, and significant epistaxis were noted. Pneumothorax was distinguished from chest tube-related air leak (frequent after cardiac surgery), which was defined as a small pneumothorax with no clinical impact that resolved spontaneously after chest tube removal. RESULTS: During the 1-y study period, there were 177 HFNC episodes, involving 145 subjects with a median (interquartile range) age of 8 (2-28) months. HFNC was used as primary support in 31% of episodes, after extubation in 36% and after NIV in 18%. HFNC was administered exclusively for nitric oxide delivery in 16% of episodes. Two children (1%) developed new pneumothoraces that required chest tube insertion, whereas 5 (3%) chest tube-related air leaks were noted. One (0.6%) episode of significant epistaxis was noted. Among 6 preexisting pneumothoraces, none worsened under HFNC. Failure of HFNC occurred in 32 episodes, requiring transition to NIV in 28 cases and endotracheal intubation in 5 cases. CONCLUSIONS: Support with HFNC following a clinical protocol in pediatric ICUs was associated with a relatively low rate of complications. Since HFNC use is increasing, further evidence is needed to confirm its efficacy and safety. Key words: high-flow nasal cannula; children; barotrauma; pediatric ICU; pneumothorax; noninvasive ventilation; complications. [ABSTRACT FROM AUTHOR]
Published: 2016
Full Text: View/download PDF

19. Impact of inborn errors of metabolism on admission and mortality in a pediatric intensive care unit.

Author: Jouvet, Philippe, Touati, Guy, Lesage, Fabrice, Dupic, Laurent, Tucci, Marisa, Saudubray, Jean Marie, and Hubert, Philippe
Subjects: *PEDIATRIC intensive care, *INBORN errors of metabolism, *NEWBORN infants, *MITOCHONDRIAL pathology, *ARTIFICIAL respiration, *HOSPITAL admission & discharge, *INTENSIVE care units, *PATIENTS, *PEDIATRICS, *RETROSPECTIVE studies, *HOSPITAL mortality
Abstract: The authors conducted a retrospective analysis of the patients admitted to a pediatric intensive care unit (PICU) during a five-year period, with specific focus on those with a suspected or confirmed diagnosis of inborn errors of metabolism (IEM), in order to ascertain the resources required to care for these patients. Medical records were reviewed for all admissions between January 1998 and December 2002 in a single metabolic referral center, and a subset of patients were identified with suspected IEM at admission or diagnosed IEM at hospital discharge. These patient charts were then further reviewed and the following information was extracted: IEM diagnosis, demographic data, biochemical characteristics at admission, need for mechanical ventilation, use of extracorporeal removal therapy, and outcome at PICU discharge. The study population comprised 70 patients (2.2% of all admissions during the study period) and included 33 neonates and 37 children aged >28 days. IEM diagnosis was known at the time of admission to the PICU in 9/33 of the neonates and 23/37 of the older children. Forty-three of the patients required invasive mechanical ventilation, while continuous extracorporeal removal therapy was used in 27 children. The median length of PICU stay was 3 days (range, 1 to 13 days) and 20 patients (28.6%) died. In conclusion, these observations show that inherited metabolic disease may be as frequent a primary diagnosis as septic shock in some PICUs. In neonates, these diseases are not usually diagnosed prior to PICU admission. Patients with IEM admitted to a PICU require aggressive support (including mechanical ventilation and extracorporeal removal therapies), and consume significant resources for relatively short PICU stays. These patients constitute a significant diagnostic and therapeutic challenge for pediatric intensivists. [ABSTRACT FROM AUTHOR]
Published: 2007
Full Text: View/download PDF

20. Diaphragm electrical activity monitoring as a breakpoint in the management of a tetraplegic child.

Author: Mortamet, Guillaume, Proulx, François, Crulli, Benjamin, Savy, Nadia, Jouvet, Philippe, and Emeriaud, Guillaume
Published: 2017
Full Text: View/download PDF

21. Improving interhospital paediatric transport.

Author: Jouvet, Philippe and Lacroix, Jacques
Subjects: *PEDIATRICS, *INTENSIVE care units, *HOSPITALS, *PATIENTS
Abstract: The author comments on the study, on the patients outcomes of unplanned admissions to paediatric intensive care units (PICUs) in Great Britain. According to the study, patients' outcomes were better when patients were transferred from local hospitals rather then from wards within the same hospital as the PICU, and survival rate among critically ill children was better when the children from other hospitals were transported by specialist retrieval teams rather than non-specialist teams.
Published: 2010
Full Text: View/download PDF

22. Évaluation d’un outil informatisé pour soutenir la prescription dans un établissement de santé pédiatrique : sécurité de l’usage des médicaments en pré et post-implantation

Author: Liang, Man Qing, Motulsky, Aude, and Jouvet, Philippe
Subjects: pharmacy, pediatrics, prescription électronique, pharmacie, pédiatrie, medication safety, vulnerability analysis, health information technology, usability, erreurs de médicaments, computerized provider order entry, medication errors, analyse de vulnérabilité, clinical decision support system, sécurité de l’usage du médicament, utilisabilité, medication use process, technologies de l’information en santé, circuit du médicament, système informatisé d’entrée d’ordonnances, système d’aide à la décision
Abstract: La prescription électronique, définie comme la saisie et la transmission électronique de diverses données de prescriptions (médicaments, requêtes de laboratoires, imagerie), est une technologie qui promet d’augmenter la productivité de l’exécution d’une prescription, de diminuer les erreurs reliées à l’illisibilité des prescriptions manuscrites et d’améliorer l’usage approprié des médicaments. Toutefois, la réalisation des bénéfices associés à cette technologie dépend grandement du contexte local de l’implantation et la configuration du système, qui doivent être adaptés aux besoins de l’établissement de santé et aux pratiques locales des professionnels. Bien que la prescription électronique soit implantée depuis plus d’une décennie dans plusieurs établissements de santé à travers le monde, il s’agit d’une technologie émergente au Québec et au Canada. Le Centre hospitalier universitaire (CHU) Sainte-Justine est l’un des premiers établissements de santé au Québec qui a implanté un système informatisé d’entrée d’ordonnances (SIEO) en 2019. L’outil, développé par un fournisseur local, a été adapté spécifiquement aux besoins de cet hôpital pédiatrique. Ainsi, l’objectif principal de ce mémoire est d’évaluer les effets de ce SIEO sur la sécurité de l’usage des médicaments. Plus spécifiquement, ce mémoire vise à 1) mesurer et décrire les problèmes liés à l’usage des médicaments avant et après l’implantation du SIEO, 2) identifier les caractéristiques du SIEO qui influencent la sécurité de l’usage des médicaments et 3) formuler des recommandations pour optimiser les bénéfices de l’outil de prescription électronique pour les patients et les utilisateurs. Afin de répondre à ces objectifs, ce travail présente deux études distinctes : 1. Une première analyse heuristique de l’utilisabilité portant spécifiquement sur la vulnérabilité du système a été effectuée en préimplantation du SIEO. Des scénarios visant à identifier les vulnérabilités du système ont été élaborés, puis un score permettant de noter la capacité du système à pallier ces vulnérabilités a été attribué par trois experts indépendants, afin de formuler des recommandations sur le design des fonctionnalités clés de cet outil. 2. Une étude observationnelle pré-post a été menée dans la période précédant l'implantation du système, et suivant l'implantation du système, dans l'unité pilote de pédiatrie générale. L’étude observationnelle est composée de deux volets, soit : a) une analyse des erreurs liées aux prescriptions de médicaments pour un échantillon d’ordonnances rédigées pendant une semaine par une analyse des interventions des pharmaciens et un audit de conformité des prescriptions et b) une analyse pré-post des erreurs liées au circuit du médicament, à partir des rapports d’incidents et accidents déclarés en lien avec le médicament. Les types d'erreurs ont été analysés afin de bien comprendre leur nature, ainsi que le rôle potentiel de la technologie sur la sécurité de l’usage des médicaments. Ces analyses ont été contextualisées par une description des fonctionnalités du SIEO (par l’utilisation d’outils validés pour l’évaluation des SIEO), des flux cliniques (par l’observation directe), et du projet d’implantation (par l’analyse de documents et des discussions avec les parties prenantes) afin de formuler des recommandations visant à optimiser les bénéfices du SIEO. Le premier article rapporte l'analyse de l'utilisabilité (étude 1) et des problèmes liés à la prescription de médicaments (étude 2a). Les résultats suggèrent que le système d’aide à la décision intégré au SIEO ne disposait pas de fonctionnalités recommandées pour limiter les vulnérabilités liées à l’usage de ce type d’outil. Néanmoins, les erreurs de conformité, qui représentaient la majorité des problèmes de prescription avant l’implantation ont été complètement éliminées par le nouveau SIEO. Toutefois, il n’y a pas eu de différence sur les erreurs de dosage et les autres interventions des pharmaciens. Ainsi, les résultats obtenus confirment qu’il est nécessaire de configurer un système d’aide à la décision avancé et adapté aux soins hospitaliers pédiatriques afin de réduire davantage les erreurs cliniques liées aux ordonnances de médicaments. Le deuxième article présente l’analyse des rapports d’incidents et accidents (étude 2b), et vise à estimer les effets du SIEO sur la sécurité de l'usage des médicaments, ainsi que mieux comprendre les erreurs de médicaments dans l’ensemble du processus des soins. L’article met en évidence le rôle important de la prescription électronique dans la simplification des étapes de la relève, de la transmission et de la transcription de la prescription. De plus, l'amélioration de l’utilisabilité de la feuille d’administration des médicaments électronique (FADMe) pourrait contribuer à réduire davantage le nombre d'erreurs liées au médicament. Ces deux articles permettent d’explorer les liens entre les caractéristiques du SIEO et les effets sur la sécurité de l’usage des médicaments, durant l’étape de prescription spécifiquement ainsi qu’à travers l’entièreté du circuit du médicament. Des recommandations sur l’utilisabilité du système et des stratégies de prévention sont présentées afin de réduire les erreurs liées au médicament., Computerized provider order entry (CPOE), defined as a system used for entering and transmitting orders (e.g., for drugs, imaging, or lab requests) electronically, is a technology that can increase the productivity of order dispensing, reduce errors related to the illegibility of handwritten prescriptions and increase the appropriate use of medication. However, achieving the benefits associated with this technology depends on the local context of the implementation and configuration of the system, which must be adapted to the needs of the healthcare institution and the local practices of the healthcare professionals. Although CPOEs have been implemented for more than a decade in many healthcare institutions worldwide, it is an emerging technology in Quebec and Canada. The Centre hospitalier universitaire (CHU) Sainte-Justine is one of the first healthcare institutions in Quebec to implement a CPOE system in 2019. The CPOE, which was developed by a local vendor, was tailored specifically to meet the needs of the CHU Sainte-Justine's pediatric inpatient population. Thus, this study aims to evaluate the effects of the CPOE on medication safety. More specifically, this study seeks to 1) measure and describe problems related to medication use before and after the implementation of the CPOE, 2) identify the characteristics of the CPOE that influence medication safety, and 3) provide recommendations to optimize the benefits of the CPOE for patients and users. To address these objectives, two studies were conducted: 1. An expert-based heuristic vulnerability analysis of the system was performed to analyze the usability of the CPOE in the pre-implementation phase. Scenarios to identify system vulnerabilities were developed, and a score to rate the CPOE's ability to address these vulnerabilities was assigned by three independent experts to make recommendations on the design of the CPOE's key features. 2. A pre-post observational study was conducted prior to and following the CPOE implementation in the general pediatrics unit. The observational study included two components: a) An analysis of medication orders problems for a sample of prescriptions ordered for one week through the documentation of pharmacists’ interventions and a prescription conformity audit; b) An analysis of medication-related incident and accident reports throughout the year in pre and post implementation. The types of errors were described to understand their nature, as well as the potential role of technology on the safety of medication use. The analyses were contextualized with descriptions of the CPOE features (through the use of validated tools for CPOE evaluation), clinical workflows (through direct observation) and implementation project (through secondary document analysis and discussions with stakeholders) in order to make recommendations to improve medication safety. The first article covers the vulnerability analysis (study 1) and the medication orders problems at the prescribing step (study 2a). The results show that the clinical decision support system (CDSS) integrated into the CPOE lacked the recommended features to identify pediatric order errors. Conformity errors, which accounted for most prescribing errors, were completely eliminated by the prescriber implementation. However, there was no difference in dosing errors and other pharmacist interventions. Thus, the results obtained from these two components suggest the need to configure an advanced CDSS tailored to pediatric hospital care to further reduce clinical errors. The second article, focused on the analysis of incident and accident reports (study 2b), aims to estimate the impacts of the electronic prescriber on medication safety, as well as to better understand medication errors in the overall care process. The article highlights the importance of simplifying the acknowledgment, transmission, and transcription steps by implementing a CPOE. Improving the usability of the electronic medication administration record (eMAR) could further reduce medication errors. These two articles explore the relationship between the characteristics of the CPOE and their impact on medication safety, specifically at the prescribing step and throughout the entire medication management process. Recommendations on system usability and other prevention strategies are presented to improve medication safety.
Published: 2023

23. Évaluation hémodynamique par thermographie infrarouge chez l’enfant après une chirurgie cardiaque

Author: Bridier, Armelle and Jouvet, Philippe
Subjects: pediatrics, low cardiac output, ratio d’extraction en oxygène, pédiatrie, hemodynamic monitoring, chirurgie cardiaque, monitoring hémodynamique, oxygen extraction ratio, bas débit cardiaque, Infrared thermography, gradient thermique, Thermographie Infra rouge, thermal gradient, cardiac surgery
Abstract: Introduction : L’évaluation hémodynamique des patients critiques est difficile et l'estimation du débit cardiaque par le clinicien est peu fiable. La chaleur des extrémités est utilisée pour évaluer la perfusion périphérique mais reste très subjective. Un gradient thermique élevé entre la température centrale et la température périphérique a été corrélé à une augmentation des résistances vasculaires systémiques et une diminution du débit cardiaque. L'objectif de cette étude est d'évaluer la relation entre le gradient thermique, obtenu par thermographie infra-rouge (TIR), et le ratio d'extraction d'oxygène (O2ER) chez les enfants de 0 à 18 ans ayant eu une chirurgie cardiaque avec circulation extracorporelle. Méthode : Étude observationnelle prospective portant sur les enfants en post opératoire de chirurgie cardiaque avec une circulation extracorporelle. Le gradient thermique entre la température centrale (cantus interne de l’oeil) et périphérique (hallux) obtenue par TIR a été comparé à l’O2ER concomitant dans les 24 premières heures post opératoires. Résultats : 41 patients ont été inclus. Une corrélation faible a été retrouvée entre le gradient thermique et l’O2ER (r = 0.25 p = 0.016). Cette corrélation augmentait pour des niveaux d’O2ER plus élevés. La spectroscopie par proche infra-rouge (NIRS) cérébrale avait aussi une corrélation significative avec le gradient thermique (r = -28 p=0.001). Seul l’âge influençait significativement le gradient thermique. Les agents vasopresseurs et vasodilatateurs n’exerçaient aucune influence. Conclusion : Une corrélation significative mais faible a été retrouvée entre le gradient thermique par thermographie infrarouge et l’O2ER après une chirurgie cardiaque pédiatrique. Une caméra thermique plus sensible et l’acquisition de mesures plus précises du gradient thermique à partir d’un plus grand effectif pourraient améliorer nos résultats., Introduction: Hemodynamic assessment of critical patients is challenging, and clinician estimation of cardiac output is unreliable. Extremity heat is used to assess peripheral perfusion but remains highly subjective. A high thermal gradient between core and the peripheral temperature has been correlated with increased systemic vascular resistance and decreased cardiac output. The objective of this study was to evaluate the relationship between the thermal gradient obtained by infrared thermography (IRT) and the oxygen extraction ratio (O2ER) in children aged 0 to 18 years, after cardiac surgery with cardiopulmonary bypass. Method: Prospective observational study of children undergoing postoperative cardiac surgery with cardio-pulmonary bypass. The thermal gradient between the central (inner eye cantus) and peripheral (hallux) temperatures obtained by IRT was compared with concomitant O2ER in the first 24 hours postoperatively. Results: 41 patients were included. A weak correlation was found between the thermal gradient and O2ER (r = 0.25 p = 0.016). This correlation increased for higher O2ER levels. Cerebral near infrared spectroscopy (NIRS) also correlated significantly with thermal gradient (r = -28 p=0.001). Only age significantly influenced the thermal gradient. Vasopressor and vasodilator agents had no influence. Conclusion: A significant but weak correlation was observed between thermal gradient by IRT and O2ER after pediatric cardiac surgery. A more sensitive thermal camera and acquiring of more accurate thermal gradient measurements from a larger population could improve our results.
Published: 2022

24. Processus de validation d’une base de données haute résolution dans une unité de soins intensifs pédiatriques

Author: Mathieu, Audrey and Jouvet, Philippe
Subjects: Database, Critical care, Pédiatrie, Electronic health record, Base de données, Dossier clinique informatisé, Soins intensifs, Pediatrics
Abstract: Objectif : Notre objectif était d’évaluer la qualité des données de la base de données haute résolution (BDHR) implantée dans l’unité de soins intensifs pédiatriques (USIP) de l’Hôpital Sainte-Justine (HSJ). Type d’étude : Un rapport descriptif et une analyse d’une étude prospective de validation d’une BDHR. Environnement : Une USIP de 32 lits, adaptée aux soins médicaux, chirurgicaux et cardiaques dans un centre tertiaire mère-enfant du Canada. Population : Tous les patients admis à l’USIP et ayant un monitorage d’au moins 1 signe vital par un moniteur cardio-respiratoire. Mesures et résultats principaux : Entre juin 2017 et août 2018, les données de 295 jours de patients ont été enregistrées à partir des appareils médicaux et 4465 données ont été filmées et comparées aux données correspondantes dans la BDHR de l’USIP de l’HSJ. Les analyses statistiques ont démontré en général une bonne corrélation, une excellente fiabilité et un bon agrément. Les graphiques de Bland-Altman ont aussi démontré l’exactitude et la précision entre les données récoltées et les données filmées selon les limites d’agrément cliniquement significatives préalablement définies. Conclusions : Cette étude de validation exécutée sur un échantillon représentatif a démontré que la qualité des données était globalement excellente., Objective: Our objective was to evaluate the data quality of our high-resolution electronic database (HRDB) implemented in the pediatric intensive care unit (PICU) of HSJ. Design: A descriptive report and analysis of a prospective validation of a HRDB. Setting: A 32 beds pediatric medical, surgical and cardiac PICU in a tertiary care free-standing maternal-child health center in Canada. Population: All patients admitted to the PICU with at least one vital sign recorded using a cardiorespiratory monitor connected to the central monitoring station. Measurements and Main Results: Between June 2017 and August 2018, data from 295 patient days were recorded from medical devices and 4,645 data points were video recorded and compared to the corresponding data collected in the HSJ-PICU HRDB. Statistical analysis showed excellent overall correlation, agreement and reliability. Bland-Altman analysis showed excellent accuracy and precision between recorded and collected data within clinically significant pre-defined limits of agreement. Conclusions: This prospective validation study performed on a representative sample showed excellent overall data quality.
Published: 2020

Catalog

Books, media, physical & digital resources

See catalog results

Searchworks

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources

Refine your results

24 results on '"Jouvet, Philippe"'

1. How to manage ventilation in pediatric acute respiratory distress syndrome?

2. It is too early to declare early or late rescue high-frequency oscillatory ventilation dead.

3. Understanding the global epidemiology of pediatric critical illness: the power, pitfalls, and practicalities of point prevalence studies.

4. Mechanical ventilation strategies in children with acute lung injury: a survey on stated practice pattern*.

5. Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit

6. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

7. Association of pediatric cardiac surgery-associated acute kidney injury with post-discharge healthcare utilization, mortality and kidney outcomes.

8. Validation process of a high‐resolution database in a paediatric intensive care unit—Describing the perpetual patient's validation.

9. Quantitative Assessment of Spontaneous Breathing in Children: Evaluation of a Depth Camera System.

10. Qualitative subjective assessment of a high‐resolution database in a paediatric intensive care unit—Elaborating the perpetual patient's ID card.

11. Intérêt de la ventilation non invasive en réanimation pédiatrique : doit-on espérer un autre niveau de preuve ? Non-invasive ventilation in children: Do we need more evidence?

12. Impact of Spontaneous Breathing Trial on Work of Breathing Indices Derived From Esophageal Pressure, Electrical Activity of the Diaphragm, and Oxygen Consumption in Children.

13. Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit.

14. When the Children Control the Ventilator, They Adopt an Appropriate Ventilation with a Strict Control of Blood pH.

15. Acute pediatric hyperammonemia: current diagnosis and management strategies.

16. Patient-ventilator asynchrony during conventional mechanical ventilation in children.

17. 2009–2010 Influenza A(H1N1)-related critical illness among Aboriginal and non-Aboriginal Canadians.

18. Modalities and Complications Associated With the Use of High-Flow Nasal Cannula: Experience in a Pediatric ICU.

19. Impact of inborn errors of metabolism on admission and mortality in a pediatric intensive care unit.

20. Diaphragm electrical activity monitoring as a breakpoint in the management of a tetraplegic child.

21. Improving interhospital paediatric transport.

22. Évaluation d’un outil informatisé pour soutenir la prescription dans un établissement de santé pédiatrique : sécurité de l’usage des médicaments en pré et post-implantation

23. Évaluation hémodynamique par thermographie infrarouge chez l’enfant après une chirurgie cardiaque

24. Processus de validation d’une base de données haute résolution dans une unité de soins intensifs pédiatriques

Catalog

Searchworks

Select search scope, currently: Articles Catalog books, media & more in Jio Institute collections Articles journal articles & other e-resources

Search

Search Constraints

Refine your results

Search Limiters

Topic

Publication Year Range

Language

Publication Type

Journal

Region

Database

Publisher

24 results on '"Jouvet, Philippe"'

Search Results

Catalog

Select search scope, currently: Articles

Catalog

books, media & more in Jio Institute collections

Articles

journal articles & other e-resources